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Acute respiratory distress syndrome (ARDS) causes 75,000 deaths in the U.S.,
annually. It is characterized by hypoxemia and damage to the lung alveoli. ARDS
Management strategies involve extracorporeal membrane oxygenation (ECMO) and
mechanical ventilation, but none of these methods improve the mortality rates. Oxygen
microbubbles (OMBs) consist of a lipid shell with an oxygen core and have potential to
augment oxygenation to manage ARDS. Previous studies demonstrated significant
improvements in systemic oxygenation and mortality upon administering OMBs.
We replicated an ARDS rat model by intratracheal administration of
lipopolysaccharide at a 24 mg/kg dose. After inducing the disease in rats, the
distearoylphosphatidylcholine (DSPC), dibehenoylphosphatidylcholine (DBPC), or
dipalmitoylphosphatidylcholine (DPPC) OMBs were administered intraperitoneally at a
100 mL/kg dose every 12 h, up to 36 h. Arterial blood gas analysis and pulse oximetry
were then performed. Results showed 77.8%, 20%, and 10% survival in the DSPC,
DBPC, and DPPC groups. Rats in the first group had significantly greater survival than

others. Beyond 12 hours, the mean %SpO2 and PaO2 of rats was greater in the DSPC
group. Additionally, the mean edema score, wet/dry ratio, and inflammation scores were
lower in the DSPC group.
The rheological behavior was characterized using a rotating rheometer. The
oxygen microbubbles showed a shear-thinning behavior. The results also showed that the
viscosity decreased with a decreasing volume fraction and increasing temperature. Lipids
with longer chain lengths showed greater viscosities and greater storage and loss moduli.
The viscoelastic behavior at lower angular frequencies was predominantly viscous. At
greater frequencies, the behavior was predominantly elastic. These results explain the
behavior of OMBs when acted upon by a stress. Non-Newtonian fluid models (Casson,
Herschell-Bulkley, Power-law) were fit to the shear stress-shear strain data and the R2
and best-fit parameters were obtained to assess the fit. The viscoelastic behavior provides
insight into the structure, molecular weight, and temperature-dependent properties of a
material.
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CHAPTER 1 RESEARCH OBJECTIVES
The work reported in this dissertation involves testing oxygen microbubbles
(OMBs) with different lipid shells in lipopolysaccharide (LPS)-induced acute respiratory
distress syndrome (ARDS) rat model. ARDS affects roughly 100,000 people in the U.S.
alone and leads to 75,000 deaths annually [1]. In this work, the ARDS rat model was
replicated using a 24 mg/kg dose of LPS and the intraperitoneal (IP) administration of
oxygen microbubbles (OMBs) with lipid shells of different chain lengths investigated
with the future objective of augmenting oxygen supplementation in hypoxic patients.
The first objective of this study was to administer DSPC, DBPC, and DPPC lipid
OMBs in a rat model of ARDS to compare survival outcomes, oxygenation, and lung
damage. For this purpose, LPS was administered to rats to induce a direct lung injury via
intratracheal aerosolization. The rats were divided into three groups (10 rats, each with 5
males and 5 females) for each OMB type. The respective OMBs were administered once
every 12 h up to 36 h via IP catheters using a 100 mL/kg bolus. The rats were studied for
48 h, after which the remaining rats were euthanized.
The second objective of this study was to use rheometry characterize the
rheological and viscoelastic behavior of OMBs and model the viscous behavior using
non-Newtonian fluid models. The OMBs with different shells were characterized for their
viscous behavior by investigating their viscosity with the applied shear rate as a function
of the OMB volume fraction, the lipid type, and applied temperature. Further,
mathematical models of non-Newtonian fluids (Casson, Herschell-Bulkley, and Powerlaw) were fitted to the shear stress versus shear rate data using non-linear regression to
understand the flow behavior. Additionally, the yield stress was determined as a function
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of the OMB shell-type using the best-fit parameters. To characterize the viscoelastic
behavior of the OMBs, frequency sweep tests were used. The variation in the storage and
loss moduli was investigated as a function of the applied frequency, volume fraction, and
temperature. The goals of this study were to understand the role of the lipid type of the
OMBs in their flow behavior and the effectiveness of the different lipid shell OMBs in
improving the survival rates in conditions of ARDS.
This dissertation reports results on the use of OMBs to supplement oxygenation in
improving the survival rates in ARDS conditions and the rheological aspects of OMBs.
The dissertation is divided into parts A (literature and background) and B (experimental).
The introduction and background consist of sections that provide information on the
basics of respiration, followed by details on ARDS and existing oxygen supplementation
methods. Finally, an introduction to the various fluid rheological properties has been
provided with relevance to the rheology of OMBs. The experimental part reports the
results from the in vivo study and rheometry.
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PART-A LITERATURE AND BACKGROUND
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CHAPTER 2 ANATOMY AND PHYSIOLOGY OF THE HUMAN
RESPIRATORY SYSTEM
Respiration is a critical function in the body of a living being. Different metabolic
processes depend on the body's respiration. The rate of oxygen consumption in the
different body organs depends on the metabolic requirements. The respiratory system's
primary function is to enable gaseous exchange at the site of tissues and maintain acidbase balance [2]. However, the respiratory system also performs functions that can be
'non-vital', like speech production, olfactory sensing, and straining efforts (during
defecation and childbirth). The complex anatomy of the respiratory system is responsible
for performing the functions mentioned above. The respiratory system of human beings
can be divided into two zones, the conducting zone (which provides a passage for
airflow) and the respiratory zone (which provides a surface for gas exchange).
The conducting zone begins with the nose, connects to the pharynx and larynx,
and ends in the terminal bronchioles (Figure 2.1). This zone humidifies the air, eliminates
debris and pathogens entering through the nose, and serves as a route for the air to flow
into the lungs. The nasal conchae increase the surface area for air reception and warming.
Further, the goblet cells lining the respiratory epithelium secrete mucus that aids in
warming and humidifying the incoming air. The nasal cavity connects to the pharynx,
then is connected to the trachea via the larynx. The larynx also helps in regulating the
volume of air entering the lungs. The trachea is roughly 13 cm long [3] and comprises
16-20 rings of hyaline cartilage [2] that prevent the trachea from collapsing by providing
structural support. The fibroelastic membrane of the trachea allows it to expand during
inhalation and exhalation due to stretching. These characteristics enable the flow of air
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via the trachea. The tracheobronchial tree is partitioned into 23 generations extending
from generation 0 (trachea) to generation 23 (terminal bronchioles). The airway at each
generation branches into smaller airways [3].

Figure 2.1: Anatomy of the conducting and respiratory zones [2].

The trachea branches off into the left and right bronchi at the carina. These
branches connect to the left and right lungs, respectively. The branching angle is in a
range of 35°- 90° [3]. The bronchi branch into smaller tubes (bronchioles), collectively
termed the “bronchial tree”. The bronchioles are ~1 mm in diameter and are more than
1000 in number. The muscular wall of each bronchiole allows them to accommodate any
changes in the volumetric flow rate of air via dilation or constriction. These bronchioles
then end in terminal bronchioles that join the alveoli.
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The respiratory zone begins at the intersection of the terminal and alveolar bronchioles
(Figure 2.2). This zone is directly involved in the exchange of gases. The terminal
bronchiole connects to the alveolar bronchiole to form a duct that opens into a cluster of
alveoli. The alveolar sac consists of several individual alveoli that are 200 nm wide and
can stretch during inspiration. These alveoli are internally connected via alveolar pores to
maintain equal pressure throughout the sac and consequently in the lungs. The action of
different cell types regulates the working of the alveoli. An alveolus consists of three
major cell types that have specialized functions: type-I alveolar cells, type-II alveolar
cells, and alveolar macrophages.

Alveolocapillary
membrane

Figure 2.2: Structure of the alveoli and alveolocapillary membrane [4].

Type-I cells are permeable to gases and constitute about 97% of the alveolar
surface area [2]. Type-II cells secrete lung surfactant— a liquid composed of
phospholipids and proteins. The primary function of the lung surfactant is to reduce the
surface tension of the alveoli and maintain its stability. The macrophages perform a
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cleansing action by removing any debris and pathogens that enter the alveoli.
Furthermore, the type-I cells rest on an elastic basement membrane that borders the
capillary. The alveoli and tracheobronchial tree networks are present within the lungs.
The lungs have a diaphragm beneath. The right lung occupies more volume than the left
lung and is shorter and broader. The left lung has two lobes (superior and inferior), while
the right lung has three (superior, middle, and inferior).
The gaseous exchange at the alveoli occurs by diffusion. This phenomenon is
described later. Blood flow through the capillaries surrounding the alveoli enables
diffusion between the alveolar air and the capillary blood. The pulmonary artery carries
deoxygenated arterial blood to the alveoli, whereas the oxygenated blood exits the
alveolar capillary via the pulmonary veins. The capillaries are formed by the extensive
branching of the pulmonary artery.
In addition to performing the vital function of gaseous exchange, the respiratory
system also performs immunological functions, olfactory sensing, and humidification of
the incoming air. The physiological functions of the respiratory system involve a
synergism of different structural components. The respiratory zone occupies
approximately three liters of volume to enable inspiration and expiration. The flow of air
through the conducting zone is by the bulk movement of molecules, whereas in the
respiratory zone, it is via diffusion. The diffusion is rapid (<1 sec) and depends on the
steep concentration gradient in the partial pressure of O2 between the capillaries and the
alveolar air. The normal alveolar-arterial gradient is 15 mm Hg and may go up to 38 mm
Hg in aged people. This age-dependent increase in the gradient is due to the alveolar
destruction, pulmonary collapse, and extra-pulmonary shunting [2].
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2.1 Mechanism of breathing and respiration
The lung capacity is a crucial parameter used in ventilation strategies. The
capacity can be measured using closed-circuit helium dilution, closed-circuit nitrogen
washout, and body plethysmography. Pulmonary ventilation or breathing is defined as a
cycle of inspiration and expiration of air from and to the atmosphere. This in-flow and
out-flow air is driven by the atmospheric pressure, intra-alveolar pressure, and intrapleural pressure.
The intra-alveolar pressure (Pal) is the air pressure within the alveoli. This
pressure alters at each stage of breathing. Theoretically, the pressure in the alveoli is
equal to the atmospheric pressure (760 mm Hg) as it is connected to the atmosphere via
the trachea (Figure 2.3).

Figure 2.3: Anatomy of the lungs.
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The lungs are enclosed in a cavity (pleural cavity) surrounded by a membrane called the
pleura. The pleura is double-layered and consists of the parietal (outer) and visceral
(inner) layers. The inter-pleural space is filled with a fluid secreted by the mesothelial
cells that lubricates the surfaces and reduces friction. This reduction in friction prevents
trauma during breathing. The intra-pleural pressure (Ipp) changes between the parietal
and the visceral layer. The Ipp is lower than the Pal due to the transpulmonary pressure
(Pt), given by the difference between Pal and Ipp. A higher Pt corresponds to a larger
lung.
Breathing relies on the contraction and relaxation of the diaphragm and the
muscle fibers of the thorax. During normal inspiration, the diaphragm and the intercostal
muscles are involved. The diaphragm contracts to move inferiorly towards the abdominal
cavity to increase the space available to the lungs. Further, contraction of the external
intercostal muscles pushes the ribs outwards, causing them to expand. This resulting
increase in the volume causes a decrease in pressure (below 760 mmHg in the alveoli),
causing atmospheric air to rush in. The diaphragm and intercostal muscles relax during
expiration, causing the lung to recoil. This decrease in the volume increases Pal and
pushes the air out of the lungs. Expiration is passive since it does not require energy.
After inspiration, the air enters the respiratory tract, and part of it reaches the
alveoli and undergoes gas exchange. However, a small portion of air that reaches the
alveoli does not participate in gaseous exchange and accounts for the alveolar dead
volume.
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2.2 Oxygen requirement and diffusion in the body
The air is a mixture of gases wherein each gas exerts a partial pressure according
to its composition. Nitrogen occupies 78% of the air by volume and exerts a partial
pressure (Pp) of 597 mm Hg, while air O2 covers 21% and exerts only 158 mm Hg of
pressure. This Pp of O2 in atmospheric air is greater than the value in alveolar air,
creating a steep pressure gradient between the alveoli and the atmospheric air at the
beginning of blood oxygenation. Similarly, the Pp of O2 in the pulmonary artery (PA) is
40 mm Hg, creating another gradient between the alveolar air and the blood in the
pulmonary artery. The gradients mentioned above allow for the diffusion of O2 from the
atmosphere to the alveoli and subsequently into the pulmonary vein (PV). When this
pressure difference is narrow, the body accommodates by constricting blood capillaries to
the dysfunctional alveoli and simultaneously dilating those to the functional alveoli to
increase the blood oxygenation. At the interface of the alveolar wall and the capillary
wall, diffusion of O2 occurs down the gradient through the alveolocapillary membrane.
Once diffused, the O2 enters the PV, and its Pp increases to 100 mm Hg. The O2 then
binds to hemoglobin (Hb) - a protein that contains a ring-shaped molecule 'Heme'.
The Hb has a quaternary structure consisting of 4 subunits. The binding of the
first sub-unit causes a conformational change that increases the affinity of the protein to
another O2 molecule (figure 2.4).
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Figure 2.4: The different protein chains present in a Hb molecule [2].

This way, the binding of the O2 molecule facilitates the binding of another O2
molecule until the ring is saturated. As a result, Hb gets completely saturated with O2.
The red blood cells (RBCs) then carry Hb to the different tissues to deliver O2. At the
tissue site, the Pp of O2 is only 40 mm Hg (compared to 100 mm Hg in the PV), forming
a gradient. This causes O2 from the blood to diffuse into the tissues. During this process,
the pressure gradient causes O2 to dissociate from heme. The dissociation of one
molecule of O2 facilitates the dissociation of others. The dissociated O2 then diffuses
into the tissue. Therefore, there is a range of O2 Pp for which the binding and unbinding
of O2 from the Hb is optimal. This range can be seen in the O2-Hb dissociation curve
(figure 2.5).
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Figure 2.5: O2 dissociation curve showing the relation between O2 saturation and O2 partial pressure [2].
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CHAPTER 3 BLOOD GAS ANALYSIS AND PULSE OXIMETRY
Blood gas analysis is an important technique to approximate the blood
oxygenation of an individual/animal. It utilizes the concept of light absorbance (pulse
oximetry) or electrochemical analysis (arterial blood gas analyzer). Arterial blood gas
analysis (ABG) is essential to diagnose a patient's oxygenation level and acid-base
balance in metabolic or respiratory syndrome. It utilizes three approaches for acid-base
physiology vis-à-vis HCO3- levels, standard base excess, and the strong ion difference
[5]. The metabolic and oxygenation parameters define clinical paradigms such as
respiratory acidosis or alkalosis. The calculation method for determining the oxygenation
or metabolic status utilizes electrochemical principles. For ABG, a sample of arterial
blood is used.
The consistency of the ABG report is important and can be determined by using
the Henderson equation, which is given by [5]:

[𝐻𝐻 +][𝐻𝐻𝐻𝐻𝐻𝐻3 −]
= 24
𝑃𝑃𝑃𝑃𝑃𝑃2

From the above equation, the [H+] concentration is obtained, and the pH is calculated.
This pH is then compared to the measured pH. A close agreement between the two values
indicates the validity of the analysis.
In our study, blood gas analysis was performed using a blood gas analyzer (figure
3.1). The analyzer consists of three electrodes for pH, PaO2, and PaCO2 maintained at
37° C [7]. Each of these electrodes was introduced by different researchers. Phyllis T.
Courage first introduced glass-cup-shaped electrodes for blood pH analysis in 1925.
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Almost two decades later, Poul Astrup measured the pH before and after equilibrating the
blood sample with a known PCO2 value and then extrapolated the pH of a patient to
obtain the final PCO2. A few years later, Richard Stow invented a PaCO2 electrode that
John Severinghaus modified in 1954. The modification included wrapping a thin
membrane permeable to CO2 but not H+ around the tip of the pH electrode. In the same
year, Leland Clark designed a PaO2 electrode. By putting the above electrodes together,
Severinghaus and Bradley created the first blood gas analyzer by mounting a Clark PaO2
electrode with a stirring paddle, a commercial pH, and a Stow-Severinghaus electrode in
a water bath maintained at 37° C.

Principle and components of a blood gas analyzer:
A modern-day blood gas analyzer consists of a pH-, PaO2-, and PaCO2electrodes for analyzing the blood gas parameters (figure 3.1). These electrodes may have
long equilibration and calibration times due to which the analysis typically takes 1-2
minutes. The underlying mechanisms for the working of each of the above electrodes is
based on electrochemistry principles involving the O2 concentrations and H+
concentrations.
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Figure 3.1: ABG analyzer (ABL-80 co-flex) from Radiometer.

Limitations of using the blood gas analyzer:
Despite the advantages mentioned above, there are some disadvantages of using the
analyzer:
•

The electrodes in the analyzers can get clogged with debris and lead to errors.

•

The response time can be slow depending on the system used and the specific
situation.

3.1 Pulse oximetry
Pulse oximetry (PO) is a method of determining the O2 saturation of Hb
molecules. As mentioned in section 2.2, heme can bind to four O2 atoms. When all the
four atoms bind, the Hb molecule is saturated. This saturation of the Hb molecule is
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expressed as the percentage saturation or %SaO2. The %SaO2 is related to the partial
pressure of O2 and is given by the O2 dissociation curve (figure 3.2). When %SaO2 is
measured using a probe (such as a finger clip), it is termed as %SpO2 (i.e., %SaO2
measured from the body's periphery). Currently, finger probes, collar probes (for
rodents), and forehead probes (which utilize reflectance technology) are in-use [7]. The
normal range for %SpO2 is between 95-100% for healthy individuals and 88-100% for
those with underlying chronic pulmonary pathology [8].

Principle behind pulse oximetry:
In 1973, T Aoyagi showed that the ratio of the amplitude of pulsatile variation of
light as a fraction of (a) red and (b) infrared waves is a unique function of arterial O2
saturation. Moreover, he showed that this function depends on skin color, tissue
thickness, and venous or capillary saturation [7].
Light passing through the ear or finger can be partially absorbed by blood due to
the presence of Hb. The degree of absorbance is higher for oxygenated Hb than
deoxygenated Hb [9],[11]. Therefore, the ratio of light saturation by the above two
molecules is calculated and calibrated against direct measurements of arterial gas
saturation (%SaO2) using the oxy-Hb dissociation curve. This value then provides the
peripheral O2 saturation or %SpO2. However, PO does not provide any information on
the concentration of carboxy-hemoglobin (CO-Hb). Moreover, errors can occur in the
measurement due to motion artifact and low perfusion state of the blood vessels.

17

3.2 Co-oximetry
Co-oximetry is a technique that utilizes spectrophotometry to calculate fractional
SaO2 and hemoglobin derivatives (HbO2, MetHb, COHb, Hb, and Fetal Hb). Moreover,
the hematocrit can be calculated from the conductivity of the blood sample. In order to
enable this measurement, an optical unit containing a lamp, hemolyzer, and
spectrophotometer is installed within an analyzer [12]. The components are explained as
follows:
•

Lamp: A 4W halogen lamp is used as a source of light.

•

Neon lamp: Provides a 585 nm spectral line.

•

Infrared filter: It absorbs the heat emitted.

•

Lens: The lens focuses light from the source onto a cuvette placed within the
hemolyzer.

•

Hemolyzer: It consists of an ultrasonic resonator emitting ~30 kHz waves that lyse or
rupture erythrocytes, resulting in a homogenous sample.

•

Spectrometer: It consists of photodiodes that can measure up to 128 different
wavelengths in the range of 478-372 nm.

Principle of co-oximetry:
The amount of light absorbed is calculated using the Beer-Lambert law to relate
the properties of transmitted light to the properties of the substance through which it is
transmitted.
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Limitations of co-oximetry:
•

Turbidity of more than 0.5% affects the measurement of the sample.

•

Neonates have high fetal Hb and a structure similar to COHb, that may lead to a false
value.
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CHAPTER 4 ACUTE RESPIRATORY DISTRESS SYNDROME
ARDS is a respiratory disorder characterized by hypoxemia accompanied by
diffuse alveolar damage, capillary congestion, atelectasis, interalveolar hemorrhage, and
alveolar edema [13]. Approximately 40-58% of patients diagnosed with moderate to
severe ARDS have diffuse alveolar damage and pulmonary edema. ARDS is reported in
10-86 of every 100,000 people, with the highest numbers in the United States and
Australia [13]. ARDS was first reported in 1967 by Ashbaugh et al. [14]. They observed
that 12 of 272 patients treated for respiratory support showed no improvement. Moreover,
those 12 patients experienced dyspnea, tachypnea, cyanosis, loss of compliance, and
diffuse alveolar infiltration.
The ARDS commonly occurs after a traumatic injury resulting from cutaneous
burn and smoke inhalation, near drowning, aspiration pneumonitis, sepsis, and
pneumonia [13]. The pre-COVID-19 patient mortality from ARDS was 46%, with
roughly 75,000 deaths annually in the US alone. Moreover, ARDS is among the principal
causes of COVID-19-related deaths due to a severe cytokine storm. About 33% of
hospitalized COVID-19 patients develop ARDS [15], [16]. In a recent meta-analysis
conducted on ARDS-related mortality from COVID-19, the pooled mortality was 39% in
10,815 ARDS cases and was similar to the pre-COVID-19 rates [16].

4.1 Berlin definition of ARDS
The Berlin definition of ARDS provides criteria to establish the risk strata based
on the severity of hypoxemia. According to the Berlin definition,
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•

The onset of ARDS should be within one week of a known clinical insult or
new/worsening respiratory conditions.

•

The presence of bilateral opacities is not completely explained by effusions, lung
collapse, or nodules.

•

Cardiac failure does not fully explain the presence of edema.

The categories of ARDS are defined as follows (the ratio has units of mm Hg):
•

Mild: 200 < PaO2/FiO2 ≤ 300 with PEEP ≥ 5 cm H2O.

•

Moderate: 100 < PaO2/FiO2 ≤ 200 with PEEP ≥ 5 cm H2O.

•

Severe: PaO2/FiO2 ≤ 100 with PEEP ≥ 5 cm H2O.
Based on the above information, the hallmarks of ARDS include hypoxemia,

bilateral radiographic opacities, increased pulmonary venous admixture, increased
physiological dead space, and decreased respiratory system compliance. Additionally,
lung edema, inflammation, and alveolar hemorrhage are commonly observed
morphological hallmarks. Several other definitions of ARDS were proposed in the past.
One among them is the AECC definition [17], later replaced by the Berlin definition. The
AECC definition was modified and replaced with the Berlin definition due to the
following issues:
•

The AECC definition required the onset of respiratory failure to be acute.
However, it did not provide a timeframe for this failure to occur.

•

The criteria for hypoxemia included the PaO2/FiO2 ratio without providing the
PEEP value. It is known that FiO2 can change with PEEP depending on the
ventilator settings.
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•

The criteria for bilateral infiltrates in chest radiographs have moderate interobserver reliability.

4.2 Onset and development of ARDS
ARDS progression in a phase-wise manner is explained below:
•

Exudative phase: A traumatic injury sets the cycle of ARDS events into motion.
The lung responds to this injury by initiating the exudative phase characterized by
the activation of innate immunity. As a result, the alveolar endothelium and
epithelium get disrupted due to the innate immune cell-mediated microdamage
and accumulation of protein-rich edema within the interstitium and alveoli. The
edema fluid leaks into the alveoli from the surrounding capillaries when the
endothelium gets disrupted, marking the onset of the exudative phase (figure 4.1).
The surrounding alveolar macrophages secrete IL-1β, 6, 8, and TNF-α proinflammatory cytokines. Secretion of cytokines results in the infiltration of
neutrophils and monocytes and activation of the alveolar epithelial cells and
effector T cells. Moreover, intravascular coagulation can occur in the capillaries
leading to platelet aggregation and the formation of microthrombi.
Pathophysiologically, in this phase, alveolar edema and alveolar collapse interfere
with oxygenation due to atelectasis from the loss of surfactant-related alveolar
stabilization. The surfactant is washed out of the alveoli and inactivated by
alveolar edema.
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•

Proliferative phase: In this phase, the body initiates repair processes. The
epithelial layer is repaired with reabsorption of alveolar edema fluid by
aquaporins and via interstitial drainage (figure 4.2). The tight junctions and
adherens junctions of the epithelial membrane are restored, and a transient
proliferation of fibroblasts leads to the formation of a provisional matrix.
Similarly, endothelial cell proliferation leads to the restoration of the endothelial
membrane. Typically, the proliferative phase begins 5-10 days after the exudative
phase.

•

Fibrotic phase: This phase does not occur in all individuals suffering from
ARDS and is strongly associated with prolonged mechanical ventilation (figure
4.2). In the fibrotic phase, the alveolar ducts, alveoli, and the interstitium undergo
fibrosis due to extensive basement membrane damage and delayed
reepithelialization. Type II alveolar cells, fibroblasts, and myofibroblasts
proliferate in this phase. Moreover, the lungs show bullous changes and may
show emphysema. The fibrotic phase may occur up to two weeks post-initial
insult.
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Figure 4.1: Exudative phase of ARDS showing disrupted endothelial membrane and consequent
alveolar flooding [18].
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Figure 4.2: Progression of ARDS from proliferative to fibrotic phase [18].
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Researchers have proposed three hypotheses for the cause of ARDS- infection,
inflammation, and direct toxicity [18].
•

Infection: Infection develops in 20-45% of the patients diagnosed with severe
sepsis and is exacerbated via the increase in vascular permeability of albumin,
disruption of the blood clotting cascade in the lungs, and impairment of the
lung metabolic functions. Moreover, bacteria adhere to the injured
endothelium leading to the progression of sepsis resulting in acute
inflammation initiating ARDS. The above events are triggered primarily by
recognizing bacterial endotoxins (like lipopolysaccharides) that trigger an
inflammatory response from the immune system.

•

Inflammation: A strong implication for the inflammatory response in ARDS
exists [18]. The oxygen radicals and proteases initiate such an inflammatory
response, and other inflammatory mediators are released by the neutrophils.
These agents induce lung injury by activating cell apoptosis via the Fas
ligand. As a result, Fas ligand accumulates in patients' lungs, inducing
apoptosis of epithelial cells. Biologically active Fas ligand accumulates in the
lungs of ARDS patients.

•

Direct toxicity: Direct lung injury can occur via putative agents such as
mechanical forces during ventilation, aspiration of toxic gases, aspiration of
water (in case of near drowning), exposure to high temperatures, or direct
chest trauma. Within hours of such an injury, pro-inflammatory mediators can
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release into the lungs. The injured lung is infiltrated by neutrophils and fibrin,
causing damage to the epithelium in the airways and alveolar walls.
As mentioned in the above discussion, the flooding of alveoli due to edema
reduces the surface area available for the diffusion of O2 from the alveolar air to the
surrounding capillaries. Therefore, pulmonary edema is a risk factor for the worsening of
ARDS. Edema occurs when the rate of draining fluid out of the alveoli is exceeded by the
rate of fluid entering it. Edema can be of two types- increased permeability edema (as in
ARDS) and increased pressure edema (due to increased cardiac output). The fluid
exchange in the lungs in the above cases is governed by the Starling equation [18]:

Jv = Lp ∗ S[(Pc − Pi) − σd(πc − πi)]

Jv = Lp ∗ S[(Pc − Pi) − σd(πc − πi)]
Equation 4.1: Fluid filtration rate for alveoli [18].

where, Jv- the fluid filtration across the microvascular barrier (MVB) (mL s-1), Lp- the
hydraulic conductivity of MVB (cm s-1 mm Hg-1), S- the surface area of MVB (cm2), Pcthe pulmonary capillary hydrostatic pressure (mm Hg), Pi- the interstitial hydrostatic
pressure (mm Hg), 𝛑𝛑c- the capillary plasma colloid osmotic pressure (mm Hg), 𝛑𝛑i- the

interstitial fluid osmotic pressure (mm Hg), 𝛔𝛔𝛔𝛔- the average osmotic reflection
coefficient of the barrier.

Moreover, the draining of alveolar edema fluid at the molecular level depends on
the apically located sodium channel (ENaC) and the basolaterally located ATPase
enzyme (NKA). In ARDS, NKA is impaired, leading to worsening edema fluid buildup.
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Overall, the management of alveolar fluid transport depends on ENaC, NKA, and
chloride transport via the cystic fibrosis transmembrane conductance regulator (CFTR)
[18].

4.3 Management of ARDS
The initial step in ARDS management is to identify the precipitating cause to
diagnose any respiratory abnormalities. Subsequently, oxygenation is maintained at a
non-toxic FiO2 and PEEP via mechanical ventilation. Further, if the physician diagnoses
a non-respiratory abnormality, the related organ dysfunction is treated by providing
critical care and adequate nutritional support. This section discusses the importance of
oxygen therapy, followed by a discussion on mechanical ventilation and extracorporeal
membrane oxygenation (ECMO) for ARDS management.

4.3.1 Oxygen therapy
Initiating oxygen therapy early on is essential for acute care in trauma situations.
However, care is taken to ensure that oxygen toxicity is not induced in the patient's body.
Oxygen therapy dates back to the late 1800s when Joseph Priestley discovered molecular
oxygen and Lavoisier subsequently demonstrated the exchange of respiratory gases.
Consequently, inhaled oxygen started to be frequently used to treat several clinical
disorders. However, in 1899, Lorraine Smith confirmed the suspicions of Joseph Priestley
and Lavoisier regarding inhalation-induced oxygen toxicities [18]. In the early 1920s,
Meakins, Baruch, and others re-evaluated supplemental oxygen-breathing by establishing
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a threshold for oxygen inhalation that ultimately led to the advent of several oxygen
delivery systems.
The most common indications for supplemental oxygenation include arterial
hypoxemia. The objective of oxygen therapy is to counter tissue hypoxia. An average
adult consumes 225-250 mL of O2 per min. Therefore, adequate oxygenation is of prime
importance. There is a sequential drop in the O2 tension when it moves from the
atmospheric air to the tissue. The drop provides the concentration gradient along which
O2 diffusion occurs (figure 4.3). Two factors control O2 delivery to the periphery of the
body:
•

Oxygenation of the arterial blood (PaO2), and

•

Cardiac output.

The total O2 delivery can be calculated as follows:

D = K ∗ A ∗ 10

Equation 4.2: Total O2 delivery to the periphery of the body [18].

where,
D- Oxygen delivery (mL/min), K- Cardiac output (L/min), A- Arterial O2 content
(mL/dL).
Furthermore, the O2 content of arterial blood can be calculated by using the following
relation:

A = (Hb ∗ 1.34 ∗ SaO2) + (PaO2 ∗ 0.0031)
Equation 4.3: Arterial O2 content [18].
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where,
Hb- Hemoglobin concentration (g/dL), 1.34- O2 carrying capacity of Hb at 37 ◦C (mL/g),
SaO2- %O2 saturation, 0.0031- Solubility coefficient for O2.

Figure 4.3: Comparison of the partial pressure of O2 at different stages of respiration [18].

4.3.2 Mechanical ventilation
The flow of air from the atmosphere to the lungs occurs via the conducting
pathways. As mentioned previously, these pathways do not engage in gaseous exchange
but are rather ducts to allow for the flow of gases to the lungs. The transport of gases in
these pathways occurs via convection. The breathing process involves the expansion and
collapse of the lungs by changing pressure. When an individual has difficulty in
breathing, mechanical ventilation can be used. Early devices developed to achieve
ventilation were designed to increase resistance to expiratory flow and consequently
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provide positive pressures leading to PEEP. However, this approach led to a drawback
wherein patients had to exert a greater force while breathing to drop the pressure below
PEEP and atmospheric pressure to enable inspiration. Later, this drawback was addressed
by designing devices that reduced the force required during inspiration by operating at
pressures just below the PEEP [18]. As a result, the patient's lungs were always under
positive pressure. This approach to ventilation is called continuous positive airway
pressure (CPAP). PEEP and CPAP are not forms of assisted ventilation but tools to
minimize airway resistance or increase lung compliance.

Working principle of mechanical ventilators:
A mechanical ventilator has four components:
•

A stable attachment of the device to a patient,

•

A source of power,

•

A control system to regulate the timing and size of breaths, and

•

A module to continuously monitor the operation performance.

Based on the pressure required to force air into or out of the lungs, mechanical ventilators
can be categorized into negative-pressure ventilators or positive-pressure ventilators [19].
•

Negative pressure ventilators: These ventilators apply negative pressure to the
patient's body to expand and contract the chest cavity (figure 4.5). It is different
from a positive pressure ventilator in that the patient is placed inside a chamber
with the head extending out. The chamber is sealed to cut off air from the
atmosphere.

31

Air pump
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Plung

Rigid chamber
Figure 4.4: Schematic of negative pressure ventilation [11].

•

Positive pressure ventilators: These ventilators deliver air or a gaseous mixture
containing O2 to the lungs using positive pressure (figure 4.4). The ventilator
delivers gas via the patient circuit (containing flexible tubes). This circuit
connects the ventilator to a tracheostomy or endotracheal tube that extends to the
patient's throat.
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Figure 4.5: Schematic of positive pressure ventilation [11]

Mechanical ventilators may produce breathing patterns similar to lungs under normal
conditions (conventional ventilators) at 150 breaths/min, or they may produce breathing
patterns involving high frequencies with a breathing rate of 900 breaths/min (highfrequency ventilators).

Drawbacks of mechanical ventilation [20]:
Despite the importance of mechanical ventilators in supplemental oxygenation,
they are associated with O2 toxicity, volutrauma, air leaks, decreased cardiac output, and
clogging of the endotracheal tube, leading to infections. These complications fall under a
'ventilator-induced injury (VILI)'. Once sufficient ventilation is provided, the patient can
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be weaned off (gradually decreasing ventilator support). Approximately 25% of the
patients experience severe respiratory issues after weaning and need to be ventilated
again. It is also possible that certain patients cannot be weaned off and discontinuing
respiratory support may worsen respiratory mechanics. Furthermore, VILI typically leads
to lung distention for one or more of the following reasons:
•

Ventilation at high lung volumes: This leads to alveolar rupture, air leaks, and
gross barotrauma, increasing the tidal volume and causing volutrauma.

•

Ventilation at low volumes: This leads to hyaline membrane damage, pulmonary
edema, and an adverse effect on the surfactant function, causing atelectrauma.

•

Presence of biological forces: The presence of bacteria or LPS affects the lungs
via infliction of a direct injury that activates cell signaling pathways. This
condition is termed biotrauma.
In COVID-19-related ARDS, mortality rates of 50% have been reported in

noninvasively ventilated patients [21]. Schujit et al. showed that increasing the driving
pressure and mechanical power of ventilation was associated with an increased risk of
28-day mortality in ARDS patients with COVID-19 [22]. Approximately 29% (of 1122)
of the patients died within 28 days of initiating mechanical ventilation. Therefore, it is
essential to ensure safe ventilation practices to minimize the risk of mortality. Ventilation
strategies to minimize VILI include low tidal volumes, greater PEEP, low plateau
pressure, and recruiting maneuvers [20].
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4.6 Extracorporeal Membrane Oxygenation (ECMO)
ECMO is a cardiopulmonary support therapy in which blood is drained from the
vascular system and circulated outside the body for oxygenation. This oxygenated blood
is then re-infused in the body of the individual. Baffes et al. administered ECMO to
support infants with a congenital heart defect [23]. Later, ECMO was used in an adult
patient with trauma-induced, long-term respiratory failure [24]. Bartlett et al. reported the
first successful use of ECMO in neonates suffering from severe respiratory distress [25].
However, when Morris et al. failed to show the superiority of ECMO over conventional
ventilation in ARDS patients, the enthusiasm for ECMO decreased significantly [26]. In
2006, the results from the CESAR trial restored the interest of physicians and researchers
due to the improvement in survival rates of patients at six months post-severe respiratory
failure [27].
ECMO is used in the following cases:
•

The diminished ability of the heart to pump blood.

•

The inability of the lungs to supply adequate O2 to the body despite ventilator
support.

•

The inability of the lungs to expel CO2 despite ventilator support.

Therefore, indications for using ECMO can be divided into primary cardiac or respiratory
support. It is common to see more than one indication due to multiple body system
failures [28].
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Working principle of ECMO:
ECMO is administered via a machine controlled by a perfusionist. The ECMO
machine is connected via a cannula (plastic tube). The cannula can be placed in arteries
or veins of a patient's neck, chest, or legs [29]. ECMO involves the following steps:
•

The machine pumps blood to an oxygenator.

•

The oxygenator adds O2 and removes CO2.

•

The machine pumps oxygenated blood back to the patient using the same force as
the heart.
Based on the location of cannulation, ECMO can be broadly categorized into VA

(Venoarterial) or VV (Venovenous) [28]. In VA ECMO, the blood is extracted from the
right atrium or vena cava and is returned to the vascular system via the femoral, axillary,
or carotid artery. In this technique, the blood bypasses the heart and lungs, and the entire
circuit is connected in parallel to the heart and lungs. However, in VV ECMO, the blood
is taken from the right atrium. There are multiple VV cannulation configurations. The
entire circuit is connected in series to the blood and lungs.

Drawbacks of using ECMO:
The use of ECMO can lead to adverse events, including heavy bleeding from
different parts of the body (due to the use of blood thinners), kidney failure (due to
insufficient kidney perfusion), infection (due to bacterial infestation of the cannula),
stroke (hemorrhage or blood clots in the brain), and leg damage (due to inadequate blood
flow extremely distal to cannulation site) [29]. The most frequent complications from
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administering ECMO in ARDS patients include intracerebral hemorrhage and heparininduced thrombocytopenia [28]. The survival rate of ARDS patients receiving ECMO
support is less than 50%. Combes et al. reported that 35% of patients suffering from
ARDS who received VV ECMO did not survive at 60-days post-ECMO initiation [1].
Additionally, they reported that the survival rates of those receiving VV ECMO and
conventional mechanical ventilation did not differ significantly. In COVID-19-related
ARDS, the administration of ECMO is associated with 37% mortality [30]. In a recent
study conducted in Germany, ECMO-related deaths in COVID-19-related ARDS patients
was 68% [31].
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CHAPTER 5 DISEASE MODELS OF ARDS
To date, several ARDS models have been used in multiple studies. The choice of
the method depends on the severity of the injury, the time for onset of ARDS, and the
reversibility of the model. In these studies, ARDS was introduced by using oleic acid [3234], surfactant lavage [34-36], smoke-inhalation [37],[38], acid aspiration [39], and
endotoxins [40]. The focus of this section will be on the endotoxin-induced ARDS
injury, specifically involving lipopolysaccharide (LPS). The LPS is a compound in the
outer membrane of the gram-negative bacteria (E. coli) and consists of an O-specific
chain, a core, and a lipid molecule [40]. The O chain consists of oligosaccharide chains
(composed of 2-6 monosaccharides) attached to the outer region of the carbohydrate core.
The inner core consists of heptose and 2-keto-3-deoxyoctonic acid and is joined by a
ketosidic bond. This lipid is the immunologically active component of LPS.
LPS is a damage-associated molecular pattern molecule that binds to specific
receptors that activate pro-inflammatory pathways. Once LPS is administered in the body
via an intratracheal or intravenous route, the cellular response to LPS is initiated by
binding LPS to the LPS binding proteins present extracellularly and to CD14 and MD-2
receptors [41]. As a result, LPS binds to the toll-like receptor 4 (TLR-4), its central
receptor. Next, intercellular adaptor proteins bind to the TLR-4 receptor. They activate
several downstream signaling cascades that regulate the expression of pro-inflammatory
cytokines, ultimately causing the activation of the nuclear factor kappa-light-chainenhancer of activated B cells (NF-kB). As a result, inflammation is triggered within the
lungs. The LPS response depends on the amount of TLR-4 present on the surface of the
cell membrane. Moreover, it is understood that the pathophysiological pathways of LPS
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have a temporal dependence due to the differential activation of signaling molecules
during disease progression.
Respiratory LPS models can have two LPS delivery modes [41]:
•

Bronchoscopy method: This method produces a localized inflammatory response
stimulating bronchopneumonia.

•

Nebulization method: This method produces a diffuse pulmonary response.
In humans, the intravenous LPS administration triggers a clinical response that

begins with headaches and myalgia, followed by tachypnea [42]. Also, upon LPS
administration, the heart enters a hyperdynamic state with reduced contractility.
Subsequently, the coagulation system is activated, followed by upregulation fibrinolysis.
In the respiratory models of LPS, inhalation raises the body temperature by 0.5-1.5 ºC
with influenza-like symptoms [42]. Moreover, peak levels of IL-6,8,1β and TNF-α have
been reported 6 h post-LPS exposure and elevated C-reactive protein (CRP) at 24 h postLPS exposure [42].
Several research groups have routinely used LPS to induce ARDS in rat and pig
models. Mittal et al. examined the relationship between inflammation and surfactant
protein expression in rat ARDS models [43]. The rats were administered LPS
intratracheally for 72 h. The prostaglandin levels in the bronchoalveolar lavage fluid were
elevated significantly compared to the control rats. When the rats were treated with a
surfactant, the prostaglandin levels declined. Moreover, the levels of co-oxygenase were
enhanced considerably in the rats due to LPS. Liu et al. administered 400 μL of LPS
solution (4 mg/mL concentration) in the airway of rats to induce ARDS [44]. The rats
showed signs of ARDS— the SaO2 declined by 19.1%, while the PaO2 declined by
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21.7% of the original value. Moreover, the rats showed visible signs of sickness vis-à-vis
increased eye secretions and diarrhea [44].
In large animal studies, Pompe et al. reported the nebulization of LPS in pigs [45].
The pigs were anesthetized and ventilated, followed by an LPS challenge. The LPS was
nebulized until the PaO2 dropped below 90 mm Hg. This study found that the large
animal LPS model can be used as an experimental analog of endotoxin-induced ARDS.
In another study, Fink et al. evaluated the therapeutic efficacy of a leukotriene B4
receptor antagonist in a pig ARDS model [46]. To induce ARDS, pigs were infused with
250 μg/kg of LPS. Post-LPS administration, the mean arterial pressure decreased after 60
min. This study showed the suitability of animal models of endotoxin-induced ARDS to
test therapeutics. Lutz et al. induced ARDS in pigs using LPS [47]. The pigs were infused
with 100 μg/kg LPS dissolved in 500 mL saline. The PaO2 levels dropped significantly
in pigs that were administered LPS compared to controls. Moreover, the lungs of pigs in
the LPS group showed an increased leukocyte infiltration compared to the control group.
This infiltration was decreased upon administration of an aerosolized surfactant. The
oxygenation levels of the pigs also increased following the administration of the
surfactant. Stenlo et al. reported studies wherein LPS administered via endotracheal
intubation led to moderate-to-severe ARDS in the pigs [48]. Zadeh et al. investigated the
response of the eye arterioles of pigs with LPS-induced ARDS [42]. In this study, 20 mg
of LPS was dissolved in a balanced salt solution. The PaO2/FiO2 ratio of the pigs
declined markedly in the LPS-treated pigs compared to the sham-treated pigs, and they
developed moderate ARDS. Schmidhammer et al. evaluated the effect of increasing
doses of LPS on pigs [49]. The pigs were intubated, ventilated, and given LPS by a
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continuously increasing infusion of 0.5-12 μg/kg min. of LPS up to 500 μg/kg over 120
min. The PaO2 significantly dropped after just 1 h post-infusion. LPS also increased the
circulating IL-1ra levels 1 h post-infusion, and the values increased by 100-fold over 5 h.
This study showed that increased doses of LPS in pigs produced a reliable lung disease
model. In a study comparing LPS and lavage models of pig ARDS, researchers compared
the electro impedance tomography (EIT) parameters between the two models [50]. In the
lavage group, 0.9% saline solution lavage was performed at a 30 mL/kg dose and
repeated every 10 min. In the LPS group, pigs were administered LPS at a 200 μg/kg
dosage. Pigs in the lavage group achieved the PaO2/FiO2 ratio for moderate ARDS (<
200 mm Hg) within an hour of the final lavage, whereas those in the LPS group achieved
the same ratio after three hours. Moreover, the EIT parameters were greater in the lavage
group in the first four hours after the respective treatments, but this difference was not
sustained beyond 4 h. After 8 h, 100% of LPS pigs demonstrated moderate ARDS
compared to only 60% in the lavage group. Tables 5.1 and 5.2 summarize the different
animal ARDS injury models.
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Table 5.1: Different ARDS injury models
Model
Oleic acid

Lavage

Smokeinhalation
Acidinspiration

Concentration
30,50,60,75,90 μL

Outcome
At 90 μL, rats died after 30 min.

Ref.
[33]

0.185 mL/kg

Pig PaO2/FIO2 ratio declined after
10 min.

[34]

1 mL/30 g saline solution
lavage up to 8 times

Pig PaO2/FiO2 dropped to 85 mm
Hg 10 min. after lavage

[35]

30 mL/kg of 0.9% saline
solution

Pig PaO2/FiO2 < 100 mm Hg 1 h
after lavage

[50]

Douglas Fir smoke for 5-6
h for 7 day

Rat SpO2 declined

[37]

Pig PaO2/FiO2 dropped to 208 mm
Hg after 48 h

[38]

PaO2/FiO2 dropped to 116.29 ±
47.32 mm Hg

[39]

Oakwood smoke for 1-2 h
0.6 mL/kg thymoquinone
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Table 5.2: LPS-induced ARDS injury models
Concentration
150 μg/300 μL saline

Administration
route
Intratracheal

Outcome

Ref.

Increase in lung
inflammation of rats

[43]

400 μL

Intratracheal

Rat %SO2 dropped by 19%
and PaO2 dropped by 21.7%

[44]

LPS administered until
PaO2 dropped below 90
mm Hg

Intratracheal

Pig PaO2 dropped below 90
mm Hg

[45]

250 μg/kg

Intravenous

Pig mean arterial pressure
dropped

[51]

100 μg/kg

Intravenous

Pig PaO2 dropped

[47]

0.33 mg/kg

Intratracheal

2 μg/kg/min

Arterial infusion

[48]

20 mg

Intratracheal

Increase in lung
inflammation of pigs
Increase in hemodynamic
parameters of pigs
Rat PaO2/FiO2 dropped

0.5 μg/kg/min

Intravenous

Inflammation in the rat lung
increased 100-fold

[49]

200 μg/kg

Intravenous

Pig PaO2/FiO2 dropped to
200 mm Hg

[50]

7 mg/kg

Intratracheal

[52]

24 mg/kg

Intratracheal

Rat SpO2 dropped below
90%
Rat SpO2 dropped below
90%

[42]

[53]
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CHAPTER 6 ARTIFICIAL OXYGEN CARRIERS
Trauma or injury to the lungs may result in pulmonary edema. The fluid buildup
seriously impairs the gaseous exchange, leading to hypoxia. With the advent of artificial
oxygen carriers (AOCs), attempts have been made to oxygenate hypoxic tissue. An ideal
AOC should possess a high affinity to O2, short organ retention times, longer half-life,
easy miscibility with blood, and rapid release of O2 at the target tissue with a similar
release of CO2 and CO at the lungs [54]. The AOCs that are currently used are of three
types:
•

Perfluorocarbon-based (PFC),

•

Hemoglobin-based (Hb), and

•

Stem-cell based (Sc).

These AOCs are briefly described below.

6.1 PFC-based AOCs
PFCs are halogen-substituted compounds that have a strong C-F bond. As a result,
this bond cannot be easily cleaved and therefore does not form toxic metabolites in the
body [54]. PFCs hold certain advantages over blood due to their unlimited availability,
their lack of risk of disease transmittance from infusion, their lack of dependence on
donor-receiver compatibility, and their speed in loading-unloading O2 (twice as fast as
RBCs) [55]. PFCs have high O2 holding capacity due to their low molecular density
(e.g., Perfluorodecalin, a PFC, only contains 4.2 mol O2 per liter). PFCs possess specific
characteristics that make them good AOCs [54]:
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•

They exhibit high solubility of respiratory gases, which varies linearly with the
partial pressure of the respective gas.

•

High loading and unloading of O2.

•

No saturation of O2 and CO2.

•

PFCs release more than 90% of the loaded O2 to the tissue.

•

They can enhance peripheral O2 supply even in narrow capillaries during severe
lung inflammation.

•

They are cytoprotective towards RBCs.
Leland Clark and Frank Gollan synthesized fluorinated hydrocarbons to assess

their O2 carrying capacity [56]. In a well-known experiment, Clark and Gollan made
mice dive into a reservoir filled with fluorobutyltetrahydrofuran that was equilibrated
with 100% O2. This experiment showed that mice that breathed this fluid maintained
respiration for 4 h. They also showed that mice survived for several weeks when they
breathed air. This experiment laid the foundation for using O2-loaded hydrocarbons for
respiration. Later, Sloviter observed that water and polar substances are insoluble in PFCs
due to their lipophobic and hydrophobic nature [57]. In this experiment, Sloviter et al.
simulated blood plasma using a liquid fluorocarbon (FX-80) with a higher O2 carrying
capacity. He then modified the PFCs using bovine serum albumin as an emulsifier,
paving the way to using PFCs as O2 carriers. PFCs can be recognized by the
reticuloendothelial system in the human body and be opsonized. Therefore, PFCs are
modified with polyethylene glycol (PEG) to prevent this from occurring. PEG causes
steric hindrance between the PFCs and the proteins that cause opsonization, thereby
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avoiding it. However, if the circulating macrophages and monocytes opsonize the PFCs,
they are transported to the lungs, where they evaporate and leave the body.
The two most used PFCs are perfluorooctylbromide and perfluorodecalin. They
can have an O2 solubility greater than water [55]. Several PFCs have been investigated,
namely, Fluosol-DA, Perfotran, and Oxycyte. However, currently, Oxygent is the only
PFC being investigated in clinical trials. A phase III clinical trial showed a 60% PFC
emulsion to be more effective than blood and other colloids in stabilizing patients
undergoing orthopedic surgeries, thereby avoiding blood transfusions [54].
Notably, PFCs can increase oxygenation in small blood vessels (diameter less
than 0.3 mm), where the Fåhræus-Lindqvist (FL) effect is predominant. The FL effect
causes the RBCs in a narrow blood vessel to flow towards the middle of the lumen while
the blood plasma flows close to the wall. As a result, the apparent viscosity of blood
decreases in tubes of diameter between 30 µm and 300 µm. The FL effect occurs due to
the large difference in the average velocities of RBCs and plasma. As a result, the
distance of O2 diffusion from the RBCs to the vessel wall increases. PFCs are smaller
than RBCs and can occupy the spaces between the RBCs and the vessel wall. Due to the
high O2 loading capacity, O2 from the PFC is delivered directly to the RBCs to the
vessel wall.

Drawbacks of using PFCs
•

PFCs may increase mean arterial pressure, thrombocytopenia, and flu-like
symptoms.
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•

PFCs can intercalate into the lipid bilayer of the tissues of the cell and organelle
membranes.

•

PFCs can get deposited inside the Kupffer cells upon longer circulation.

•

PFCs can uncouple CYP450 monooxygenases that reduces the detoxification
capacity of the liver and adversely affects glucose and lipid metabolism.

•

The emulsions used in PFCs have poor stability.

6.2 Hb-based AOCs
Hb-based AOCs (HBCs) consist of a central ion surrounded by tetrapyrroles. A Hb
molecule that is not modified is not classified as an AOC [54]. HBCs are suitable
candidates for artificial oxygenation due to their ability to deliver O2 to the tissue without
an increased inspiratory O2 concentration. HBCs have advantages in that they avoid
donor compatibility issues due to the absence of antigens. Some of the HBCs that have
been investigated are:
•

Hemopure: It is a glutaraldehyde-polymerized bovine Hg. Its use in clinical trials
was terminated due to safety concerns.

•

Hemospan: It is a human Hb that is conjugated with maleimide-PEG. However,
due to the dependence on a human source of Hb, Hemospan was only developed
to reduce the severity of pains and complications from sickle cell anemia.

•

Sanguinate: It is a bovine-derived Hb cross-linked to PEG to mask it from the
immune system. It has been used in clinical trials and effectively improved the
survival of a few patients refusing a blood transfusion.
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•

Hemo2life: It is a Hb type extracted from lugworms investigated in a clinical trial
for kidney transplantation in 2018.

•

Several other HBCs like Hb-vesicles, ErythroMer, and HemoAct are under
investigation.

Drawbacks Hb-AOCs:
•

HBCs have a half-life of only 18-23 h compared to 120 days in RBCs.

•

When flue gases are present, the O2 in HBCs gets displaced by CO or CN-.

•

Hb from the HBCs can intercalate through the endothelial cell layer of the vessel
wall and bind to NO. As a result, the availability of NO reduces and leads to
vasoconstriction due to an exaggerated ET-1 response.

•

If not protected by a shell, the Hb in HBCs undergoes spontaneous oxidation.

•

Reperfusion of tissues with HBC after a stroke, hemorrhage, myocardial
infarction, or organ transplantation can lead to the production of O2 free radicals
due to the absence of superoxide dismutase and elastase enzymes that are always
present in RBCs.

6.3 Sc-based AOCs
Currently, there are two approaches to using stem cell-based AOCs (SSCs):
•

Differentiation of stem cells into RBC concentrates.

•

Differentiation of stem cells into various targeted cells in an oxygenated
microenvironment. However, in the case of RBCs, SCCs should lead to
nucleus-free RBCs.
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Tang et al. encapsulated human stem cells into a nanogel structure and tested them in
murine and porcine models of myocardial infarction [58]. In this study, the infarct sizes
of animals were reduced upon administration of the nanogels. More research into using
SCCs will highlight their role in improving oxygenation in critical conditions.
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CHAPTER 7 PERITONEAL MEMBRANE OXYGENATION
7.1 Peritoneum
The peritoneum is a membrane that lines the cavity extending from the respiratory
diaphragm to the pelvic floor (figure 7.1). The total surface area of the peritoneum is
roughly 1-2 m2. The ratio of peritoneal area to the bodyweight of a healthy individual is
approximately 0.284 [59]. The peritoneum is divided into three layers:
•

Parietal peritoneum (outer layer-red),

•

Visceral peritoneum (inner layer-blue),

Figure 7.1: Different layers of the peritoneum [59].

The parietal peritoneum lines the inner surface of the abdominal and pelvic walls
and the lower surface of the diaphragm [59]. The region between the parietal and visceral
peritoneum is the peritoneal cavity (PC) and is termed by anatomists as the 'potential
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space'. The PC is filled with less than 10 mL of fluid and can hold up to 20X that value
without causing any discomfort [59].

7.2 Splanchnic circulation
To fully understand the potential of using the peritoneum for oxygenation, it is
essential to understand the splanchnic circulation (SC) and the arterial blood supply to the
peritoneum. The SC is a network of arteries and veins that facilitates digestion,
absorption, maintenance of the mucosal barrier, and healing of anastomoses [60]. The SC
encompasses blood flow to the abdominal gastrointestinal organs— stomach, liver,
spleen, small intestine, and large intestine. These organs are perfused by arteries that
bring in oxygenated blood and a network of portal veins that drain the deoxygenated
blood into the liver sinusoids. The blood vessel network in the SC comprises three
branches of the abdominal aorta: the celiac artery (CA), the superior mesenteric artery
(SMA), and the inferior mesenteric artery (IMA) [60].
•

The CA has three divisions— left gastric artery, common hepatic artery, and
splenic artery. It supplies blood to the stomach, spleen, upper duodenum, and
pancreas.

•

The SMA is divided into the pancreaticoduodenal artery, intestinal arteries, and
ileocolic, right, and middle colic arteries. It supplies blood to the lower part of the
duodenum, jejunum, ileum, cecum, appendix, ascending colon, and a majority of
the transverse colon. The SMA is the largest SC vessel and accounts for at least
10% of the cardiac output.
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•

The IMA is divided into the left colic artery, the superior rectal artery, and the
sigmoid branches. It forms a watershed with the middle colic artery and supplies
blood to the distal ends of the transverse colon, descending colon, and rectum.

Hepatic artery
500 mL/min

Sinusoid

Stomach

Liver
Hepatic
veins

Portal vein
1300 mL/min

Celiac artery
700 mL/min

Spleen

Pancreas

Superior
mesenteric artery
700 mL/min

Small
intestines

Colon

Inferior
mesenteric artery
400 mL/min

Figure 7.2: The splanchnic circulation [60].

Regulation of the SC:
The cardiac output of a healthy human at rest is approximately 5-6 L/min [60] and
can increase after a meal or post-exercise. The resting splanchnic blood circulation in
humans is 30 mL min-1 100 g tissue-1 and can drop to as low as 10 mL min-1 100 g tissue-1
during low cardiac output. It can also increase to more than 250 mL min-1 100 g tissue-1
after a meal. The SC may get disturbed under diseased conditions like SIRS, sepsis, or
after anesthesia and ventilation. The SC is regulated by:
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•

Intrinsic factors: Myogenic and local metabolic factors

The metabolic factor focuses on the balance between oxygen demand and supply in the
region. Consequently, metabolites that cause vasodilation or vasoconstriction are
released. On the other hand, myogenic factors consist of mechanisms via which the
vessels respond to changes in the transmural pressures, consequently causing dilation or
constriction via Na+ and Ca2+ channel-induced contractions/relaxation of the smooth
muscle.
•

Extrinsic factors: Autonomic nervous systems

The SC receives sympathetic nerves. When these nerves are stimulated, noradrenaline
mediating alpha-adrenergic vasoconstriction may occur. This constriction plays a vital
role in stress events induced by exercise or severe hemorrhage.
•

Humoral factors: Vasoactive substances

The presence of vasoactive substances like acetylcholine, bradykinin, adenosine,
dopamine, leukotrienes, and nitric oxide causes dilation of the blood vessels. In contrast,
vasopressin, angiotensin II, prostaglandins, and endothelin-1 cause constriction of the
blood vessels.

7.3 Peritoneal dialysis
Using the peritoneum as a potential oxygenation space stems from peritoneal
dialysis. Peritoneal oxygenation is analogous to peritoneal dialysis. The microvascular
structure of the peritoneum mediates the physiological interactions between the PC and
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the systemic vasculature [61]. The microvasculature plays a vital role in enabling solute
transfer, regulating fluid dynamics, transporting nutrients, hormones, and leukocytes, and
distributing drugs and biological agents. Furthermore, the PC is lined by mesothelial cells
that reside on a connective tissue adequately perfused by the blood and lymphatic vessels.
As discussed in the section on SC, the arteries and the veins in the SC are responsible for
the perfusion and drainage of the organs, respectively. The veins draining the visceral
peritoneal and intraperitoneal organs empty into a portal vein, while the venous system of
the parietal peritoneum empties into the systemic veins. It is well known from
pharmacological studies that the administration of compounds intraperitoneally is subject
to metabolism by the liver [61].
During peritoneal dialysis, a dialyzing fluid (consisting of sugar, water, and
electrolyte) is administered to the PC via intraperitoneal catheters [61], [62]. While in the
PC, this fluid mixture exchanges waste substances like urea and creatinine from the blood
through the peritoneum. The fluid is ultimately drained and replaced with fresh fluid [62].
This complete procedure leverages the microvasculature of the peritoneum. The solute
from the blood capillaries crosses three barriers— capillary wall, interstitial tissue, and
mesothelial cell layer. Solute transport through the barriers is size-dependent and occurs
through the pores on the capillary wall. According to the two-pore theory, the capillary
wall has small pores with radii of 40-50 Å that are involved in the solute transport [61].
In terms of mass transfer principles, diffusion and convection are the mechanisms
involved in dialysis. Complications from peritoneal dialysis include peritonitis. However,
recently developed interventions seek to minimize the risk of peritonitis [62].
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7.4 The beginning of peritoneal oxygenation
The first study exploring intraperitoneal (IP) oxygen administration was reported
by Bourne et al. in 1927 [63]. In this study, eight dogs were first rendered hypoxic by
administering 12% O2 using a spirometer. Oxygen was then administered via intravenous
(IV) and IP routes. Absorption of O2 from the PC was followed by a rise in the PaO2
only in some dogs. Bourne et al. concluded that following IP administration, O2
absorption occurs at a rate sufficient to cause a diminution in an existing hypoxic
condition [63]. Later, in 1968, Morgan et al. evaluated the effect of IP administration of
H2O2 in hypoxic rabbits [64]. In this study, hypoxia was induced using 10% O2 and 90%
N2 in breathing air. Although a 2-9% increase in the O2 tension was observed initially, it
declined to a value lower than in the control rabbits (only hypoxic, no H2O2). The
authors concluded that H2O2 administration is hazardous and should not be attempted in
animals or humans.
Klein et al. tested the improvement in the oxygenation in hypoxic rats using a
peritoneal infusion of a PFC termed FC43 and haemaccel (hydrogel) [63]. In these rats,
hypoxia was induced using a gaseous mixture with low O2 content. The FC43 was
continuously perfused at 2 mL/ min. The PaO2 values were significantly greater, and
PCO2 was significantly lower than those in hypoxic rats that received haemeccel. Later,
Bilge et al. analyzed the feasibility of peritoneal oxygenation using a peritoneal
oxygenator [65]. In their study, Bilge et al. proposed two models for IP oxygenation, a
one-compartment model that assumes that the oxygenation rate is dependent on the
difference in the partial pressures of O2 between the IP fluid and the blood, and a second
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model that assumes that the blood flow limits the oxygenation rate and that all of the
blood that enters the PC leaves it at an O2 partial pressure equal to that of the IP fluid.
Model 1:
The following equation provides the O2 flux from the PC to the blood
j = k(P1 − P2) = pA(P1 − P2)

Equation 7.1: O2 flux from the peritoneal cavity to the lungs [65].

From the mass balance on P1, we get [65]:
dP1
dt

= −

k

aV

The above equation is solved to yield [65]:

ln

P1−P2

P1i−P2

(P1 − P2).

= −

KT
aV

.

where, j = rate of O2 delivery from the body to the PC (mL/s), p = permeability of the
peritoneal membrane to O2, A = area of the peritoneal membrane, K = transport
coefficient (mL O2 STPD/ Torr sec), P1 = partial pressure of O2 in the PC (Torr), P2 =
partial pressure of O2 in the body (Torr) , P1i = partial pressure of O2 in the PC at t = 0
(Torr), a = Henry’s law solubility coefficient for O2 in the infused fluid (mL O2 STPD/
Torr mL blood), V = volume of fluid in the PC, and t = time (s).
Similarly, model 2 predicts the flowrate of blood through the peritoneal cavity [65].
aV

dP
= Q [a1 (Psat − Pi) + a2 (P1 − Psat)]
dt
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It is solved to yield,
Q = aV

P1 − P1i

Psat (a1 − a2) + (a1 P2i)

t−1
2(a2) 2t 2

Equation 7.2: Flowrate of blood through the peritoneal cavity [65].

where, Q = flow rate of blood through the PC (mL/s), a1 = Henry’s law coefficient for
O2 in unsaturated hemoglobin (mL O2 STPD/ (Torr mL blood), a2 = Henry’s law
coefficient for O2 in saturated hemoglobin (mL O2 STPD/ (Torr mL blood), Psat = the
partial pressure of O2 at which hemoglobin is fully saturated (Torr), and P2i = the partial
pressure of O2 in the blood, which flows through the PC (Torr).

Model 2 predicts the upper limit on the peritoneal delivery of O2 at a particular
blood flow. The minimum blood flow possible depends on the rate of O2 delivery.
Furthermore, Bilge et al. used 13 mongrel dogs that were mildly hypoxic to study the
oxygenation of the PC. The dogs were administered perfluorodecalin (PFD) via the PC
using the oxygenator. The PaO2 of arterial blood increased 20 min. after the infusion of
perflurodecalin. A subsequent decrease in the PaO2 of the infusion fluid was also seen.
The observed decline in the PaO2 was well explained by model 1 but not by model 2.
This study showed that large amounts of O2 can be delivered by infusing the PC with an
O2 saturated fluid in acutely hypoxic animals.
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7.5 Limitations of IP oxygenation:
Although IP oxygenation has advantages in that there is no direct contact with blood,
no dependence on anti-coagulants, and risk of bleeding, there are some disadvantages.
•

The thickness of the peritoneum is more than that of the alveoli-capillary barrier,
resulting in the barrier to diffusion being greater in the IP route.

•

The surface area of the peritoneum is smaller compared to the lungs.

•

The SC only accounts for 25-30% of the cardiac output at any time, limiting the
delivery of O2 to the body.

•

The intraabdominal pressure must be carefully regulated not to surpass 12 - 15
mm Hg; otherwise, it can reduce the SC, cardiac output, and peripheral tissue O2
saturation [66]–[70].

•

Long-term cannulation into the PC increases the chances of infection and may
lead to peritonitis. [61].
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CHAPTER 8 OXYGEN MICROBUBBLES
Oxygen microbubbles (OMBs) are derived from microbubbles (MBs) that are
regularly used in the field of ultrasound for contrast enhancement. Their diameters are
usually in the range of 0.1-10 µm, similar to the diameter of RBCs. They have a gas core
surrounded by a shell composed of amphiphilic lipids, phospholipids, proteins,
surfactants, or polymers (figure 8.1) [71]. However, phospholipids are commonly used
as the lipid shell can self-assemble into a monolayer at the air-water interface and mimics
the stability of the lung surfactant [71]. The MBs are currently used for drug and gene
delivery. The gas core of the MBs provides ultrasound backscatter that assists in drug
delivery [71]. As a result, the MBs can be used as theranostic agents triggered by
ultrasound.
The lipid monolayer reaches a low surface tension that stabilizes the MBs. Van
Der Waals forces interact within the acyl chain to hold the lipid molecules together to
give the shell a solid-like character within the lipid monolayer. These forces also enable
compression and expansion of the shell during ultrasound insonification. The lipid
monolayer is easily functionalized for drug delivery, and it undergoes fragmentation to
deliver drugs when an ultrasound is applied. As mentioned above, MBs may also have a
polymer, surfactant, or protein shell [71]. MBs with albumin shells were popular in the
past. They were seen to form rigid shells due to the disulfide bridging of proteins.
Span/Tween surfactant MBs were prepared by sonification and were stable. Polymer
MBs were formed by the cross-linking and entanglement of the polymer chains. The
work described in this dissertation only involves lipid-based MBs with an oxygen gas
core and will be the focus of this section.

59

The OMB shell is used to stabilize the gas core and to enable the diffusion of O2
from the core to the outside in the presence of a pressure gradient. The lipid monolayer
allows for the diffusion via the thermal activation of pores within the lipid shell [72].
According to the energy barrier theory, pore creation on the shell occurs when the system
crosses the activation energy barrier (by overcoming the Van Der Waals forces)
necessary to create a pore. When this barrier is overcome, the lipid molecules separate
over a distance to allow for the passage of a gas molecule [73]. The gas molecules exiting
the core of the OMB cross three barriers- the lipid monolayer, a polyethyleneglycol
(PEG) brush layer, and the bulk aqueous medium [74]. The total resistance to the O2
diffusion is given by:
Rtotal = Rshell + RPEG + Rwater
Equation 8.1: Total resistance of OMB to O2 diffusion.

Figure 8.1: Oxygen microbubble with the lipid monolayer.
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8.1 Mechanical properties of the OMB shell
The gas permeation resistance explained above is a significant factor in
controlling the dissolution rate of the lipid-coated MBs [74]. During the dissolution
process, the lipid is shed from the shell continuously, whereby shorter lipid chains
accommodate the shrinking gas core. Once the O2 from the core of the OMB is
completely released, the OMBs shrink down to vesicles that are roughly 10 nm in
diameter [75]. Borden et al. reported that the MBs coated with lipids below their phasetransition temperature shed lipids in excess of those above that temperature [75].
Moreover, they reported that MBs with longer acyl chains took longer to reduce the
diameter and exhibited surface deformation and folded lipid projections indicating
negligible surface tension. A lower surface tension imparts greater stability.
The partition diffusion theory predicts a linear relationship between the shell
resistance (Rshell) and thickness (Lshell):
Rshell = Lshell/ k * Dshell
Equation 8.2: Resistance of OMB shell to O2 diffusion.

where k is the diffusion resistance and Dshell is the OMB diameter.
This relationship implies that an increase in the acyl chain length of the lipid
monolayer of the OMBs increases the permeation resistance to the flow of O2 from the
gas core to the outside [76]. Moreover, when the acyl chain length increases, the stiffness
of the lipid layer also increases, making it stiffer due to the greater attractive dispersion
forces leading to a more cohesive shell. It also increases the OMB lifetime and decreases
the shell-permeability.
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Swanson et al. explored the stability of phospholipid OMBs [77]. They used DSPC and
1,2-Dipalmitoylphosphatidylcholine (DPPC, C16:0) as shell materials for the OMBs.
They reported that DPPC had a lower phase transition temperature than DSPC and was
less stable. Moreover, the DPC-based OMBs lost all the O2 over three weeks, whereas
DSPC retained 30% gas. Overall, both the OMB types showed good stability and
released more than 50% of the O2 content over three weeks.

8.2 Viscous properties of the OMB shell
Kim et al. reported dramatic changes in the mechanical and viscous properties of
of lipids as a function of the changing chain length. They also noted that the surface
viscosity and yield stress increased monotonically with the chain length [78]. Black et al.
characterized the rheological behavior of lipid oxygen microbubbles (LOMs), analogs of
OMBs, using a parallel plate rheometer [75]. The study reported that the LOMs showed a
shear-thinning behavior (shear-dependent decrease in viscosity). When 90% (volume
fraction) LOMs were mixed with blood in a 1:1 ratio, the viscosity was lowered by two
orders of magnitude compared to the unmixed LOMs. The authors also reported similar
results on 80% and 65% volume fractions. All the volume fractions showed the shearthinning behavior. The differences between the volume fractions were insignificant at
lower shear rates. The yield stress was also found to increase exponentially with the
volume fraction.
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8.3 Pulmonary oxygenation using OMBs
Black et al. evaluated the oxygenation capacity of LOMs by administering them
intravenously to rabbits with severe hypoxia [75]. The LOMs were synthesized using
phospholipids di-stearoyl-phosphatidylcholine (DSPC, C18:0) and stabilizing surfactants.
Hypoxic rabbits were injected with a 0.2 g/kg dose of LOMs over 2 min. via the central
vein. The Hb saturation increased to normal levels during the infusion. The rabbits
receiving LOMs maintained greater oxygenation and experienced decreased metabolic
acidosis, normal blood pressure, and a lower incidence of cardiac arrest, and they showed
an 85% survival over a 90 min. duration. Moreover, they noted that the LOMs could
provide up to 4 mL/kg of O2 per rabbit in 15 min. and could supply the entire O2 demand
of the animals.
Black et al. monitored the hemodynamic effects of administering LOMs in rats
intravenously [79]. Relative to controls, rats that received LOMs showed a 20% greater
pulmonary artery pressure and pulmonary vascular resistance. Moreover, the mean
arterial pressure also decreased significantly in rats receiving LOMs. The rats receiving
fresh LOMs survived between 1-60 min. while those receiving older LOMs showed a
hemodynamic collapse and cardiac arrest. Since the OMBs tend to coalesce, their IV
administration is problematic due to clotting and thrombosis. Moreover, administering
OMBs for a longer duration can result in hypervolemia, pulmonary edema, hemodynamic
instabilities, and decreased hematocrit [75]. Previous studies from our research group
have explored the oxygenation of hypoxic animals by administering OMBs via the
peritoneal cavity.
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In a different approach to administering OMBs, Mountford and Leiphrakpam et al. tested
DSPC OMBs on a smoke-inhalation injury-induced ARDS model of pigs [80]. Colonic
infusion of OMBs at 75-100 mL/kg significantly improved the PaO2 by 13.2 ± 4.7 mm
Hg and the SpO2 by 15.2 ± 10.0% compared to the controls. Moreover, the PaCO2
declined by 19.7 ± 7.6 mm Hg compared to controls.

8.4 IP oxygenation of OMBs
As mentioned in the previous sections, the IV administration of OMBs has several
limitations and is not the preferred route for administration. The peritoneal cavity offers
an attractive option due to the SC, which accounts for 25-30% of the cardiac output.
Several studies have explored the oxygenation capacity of OMBs in hypoxic animals. In
a previous study conducted by our group, we administered DSPC OMBs (70% volume
fraction) intraperitoneally on rats experiencing a right lung pneumothorax injury [71].
The OMBs were continuously infused at 8 mL/min into the peritoneal cavity. All the
untreated rats and rats receiving saline died within 30 min., whereas those receiving
OMBs (treated) survived for at least 2 h. Moreover, the treated rats showed normal levels
of heart rate and Hb saturation. In another study testing a different lung injury model, rats
were rendered hypoxic by inducing ARDS via direct infusion of LPS through the trachea
[81]. The OMBs were continuously infused at 0.7 mL/min kg flow rate. All the rats
survived up to 24 h after the LPS aerosolization, and a short-term improvement in the
oxygenation was observed. Additionally, the OMBs could provide 60% of the rats’ O2
demand. Encouraging results from these studies led to the exploration of OMB
oxygenation in rabbits. Legband et al. tested DSPC OMBs in a rabbit model of asphyxia
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[52]. The endotracheal tube of the rabbit was hermetically sealed to prevent O2 intake.
The OMBs (or saline) were perfused at 12.6 mL/ min kg. Rabbits from the control group
survived for 6.9 ± 0.6 min. while those in the OMB group survived for 18 min. The
survival rates were found to be significantly different between the two groups.

Figure 8.2: Schematic representation of the IP administration of OMBs [89].

In a follow-up study with a larger group of 19 rabbits, DSPC OMBs were infused
intraperitoneally [82]. The rabbits were intubated followed by endotracheal tube
occlusion. Similar to the previous study, the rabbits were administered OMBs at 12.6 mL/
min kg. Rabbits receiving OMBs had a survival time of 12.2 ± 3.0 min., significantly
greater than the saline group. This compared results from the administration of OMBs
using a single bolus and by continuous perfusion of OMBs. However, this study showed
that the OMB administration did not provide 100% of a sedated rabbit's total O2 demand.
Later, Fiala et al. tested DSPC OMBs in rats with LPS-induced ARDS [51]. The ARDS
was induced via an intratracheal administration of 24 mg/kg dose of LPS. The OMBs
were then administered intraperitoneally to the injured rats, thrice every 12 h post-LPS
over a 36 h period. After each treatment, rats receiving OMBs recorded a percentage
difference in %SpO2 compared to the baseline that was significantly greater than the

65

saline or untreated counterparts. The survival of rats was significantly higher in the OMB
group (80%) compared to the saline (57%) and the untreated (43%) groups. Moreover,
the lungs of rats treated with OMBs had significantly lower edema, hemorrhage, and
inflammation scores, pointing towards a lower injury compared to the other groups.
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CHAPTER 9 AN INTRODUCTION TO THE CLASSIFICATION OF FLUIDS
AND RHEOMETRY
The OMB suspension consists of the OMB phase and the saline phase. The OMBs
are suspended in the saline solution. In order to understand the rheological behavior of
suspensions like OMBs, it is essential to understand key concepts related to fluid
rheology.
All the materials can be classified into solids and fluids [83]. Solids have a
preferred configuration, whereas fluids have no preferred configuration. By applying
scientific rigor, a fluid can be defined as any material for which every configuration of its
material body that leaves the density unchanged can be taken as a reference configuration
[83]. A Newtonian fluid (N) shows a linear relationship between the shear stress and
shear rate. Moreover, the temperature is the only factor affecting the viscosity, and there
is no temporal dependence. However, non-Newtonian (NN) fluids have stress and
temporal dependence. For fluid-particle suspensions, the NN behavior is generally
observed for solids concentrations greater than 0.4 (v/v) [84]. Understanding the
relationships between shear stress and shear strain constitutes rheology. NN fluids can be
classified into pseudoplastic (shear-thinning), dilatant (shear-thickening), and Bingham
plastic. Certain NN fluids show a temporal behavior. These fluids break down under
continued shear and on mixing to give lower shear stress (decreasing apparent
viscosity— thixotropic), or they re-assemble so that the shear stress increases with time
(increasing apparent viscosity— rheopectic). The NN fluids may also possess yield stress
that must be overcome before flow initiates.
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Most materials are neither purely viscous nor purely elastic. Such materials are
viscoelastic (VE). In the case of slow deformation (greater observation time), the viscous
behavior dominates, whereas, in a shorter observation time, the behavior is
predominantly solid [85]. Both these conditions depend on the characteristic time of the
material. Therefore, the type of behavior exhibited by the VE materials is a function of
time and can be determined by using the phase shift (or loss factor) and, consequently,
the Deborah number (De).
In this work, the viscous and VE behavior of OMBs with different shell types has
been investigated, and further discussion will only involve shear-thinning and VE fluids.

9.1 Shear thinning behavior
It is essential to consider the fluid microstructure to gain an insight into the shearthinning behavior. For suspensions containing spherical particles, the microstructure is
defined relative to the position of the particles, and it is generally accepted that the NN
behavior results from changes in the positions of these particles [84]. At lower shear
rates, the microstructure tends to be ordered, and the particles may slide past one another,
giving rise to the shear-thinning behavior. However, at greater shear rates, the
microstructure gets disordered, and the particles may not flow past each other easily,
giving rise to a shear-thickening behavior [86]. When a shear-thinning fluid is subjected
to rheometry, the apparent viscosity versus the shear rate plot shows a decreasing trend
(i.e. the apparent viscosity is lower at greater shear rates).
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9.2 Rheometer
The fluid viscosity and other steady rheological fluid parameters are determined
using a rheometer. Several rheometers are currently in use— cone and plate, parallel
plate, Couette, rotating disc, and capillary tube rheometer. The rheometer is selected
based on the consistency of the sample. However, they can be broadly categorized into
rotational, extensional, and capillary rheometers [87]. For this dissertation, only cone and
plate rheometers will be discussed.

9.2.1 Cone and plate rheometers
This rheometer consists of a fixed plate (Peltier plate for temperature control) and a
rotating geometry (cone) with a certain cone angle (figure 9.1). The geometry can have
different diameters, and a suitable diameter is chosen depending on the sample's
viscosity. The cone geometry produces a smaller gap height such that the shear on the
sample is constant throughout. As a reference, the following diameters are preferred:
•

Low viscosity (milk) – 60 mm diameter

•

Medium viscosity (honey) – 40 mm diameter

•

High viscosity (caramel) – 20-25 mm diameter

The sample is added onto the Peltier plate after adjusting the appropriate temperature.
The geometry is then attached to the rheometer and lowered to apply an angular velocity.
The geometry rotates at a constant speed when in contact, and the rheometer applies
torque to maintain the constant speed. A variation of the torque needed is used in the
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calculation of the viscosity of the sample. The shear rate is proportional to the angular
velocity, while the shear stress is proportional to the torque.

Figure 9.1: Rotating rheometer with cone geometry [87].

9.2.2 Parameters involved in cone and plate rheometer measurements
•

Strain constant: Converts angular velocity (rad/s) to shear rate (s-1)
Kɣ = 1/β,

where 'β' is the angle expressed in radians.
Therefore,
˙γ = Ω x Kɣ,
where 'Ω' is the angular velocity in rad/s, and '˙γ' is the shear rate (s-1).
The shear rate decreases with the increase in the cone angle.
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•

Stress Constant: Converts torque (Nm) to shear stress (Pa)
Kσ = 3/2πr3, where 'r' is expressed in m.

Therefore,
σ = M x Kσ
where 'M' is the torque applied by the rheometer (Nm).
The shear stress increases with the increase in the diameter.
By using the relations mentioned above, the viscosity of a sample is calculated as
µ (or µapp) =
1

σ

˙γ
2

=

M
Ω
3

x

Kσ
Kɣ
4

Equation 9.1: Viscosity calculated using rheometer parameters.

where,
1- Rheological parameter,
2- Constitutive equation,
3- Raw rheometer specification,
4- Geometric shape constant.

9.3 Viscoelasticity and rheometry
The VE materials possess a viscous and elastic behavior that depends on the
characteristic time of the material. They consist of a purely viscous and ideally elastic
behavior [85]. The Maxwell and Kelvin models are used to describe the VE behavior of
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materials. The Maxwell model uses a linear combination of a spring and dashpot,
whereas the Kelvin model uses a parallel combination of the spring and dashpot [85].
When stress is applied to a solid, it experiences a strain immediately. However, when
stress is applied to a fluid, the strain response occurs after a lag that corresponds to a
phase shift (δ).

9.3.1 Dynamic mechanical testing
Dynamic mechanical testing can be performed on a VE material using a
rheometer by using oscillatory measurements. In this method, sinusoidal stress or strain is
applied to the VE material, and the resulting strain or stress response is measured. This
analysis measures the viscous and elastic behavior and provides a good understanding of
the nature of the material under slow or fast deformations. The rheometer consists of a
motor that applies the sinusoidal stress or strain and a force transducer that measures the
response. The stress and strain are measured from the peak amplitude in the torque and
displacement waves, respectively (figure 9.2). The resulting behavior can be interpreted
as a function of time, oscillatory frequency, temperatures, stress, or strain [85]. The
rheological behavior of the VE material under oscillation testing can be adequately
explained using the Maxwell model. A phase shift (δ) is seen in the material response
owing to its viscous and elastic nature. For an ideally elastic material, δ is 0°. Whereas
for ideally viscous material, it is 90°. For VE materials, 0° < δ < 90°. At δ = 45°, the
material is equally viscous and elastic. Therefore, δ indicates the extent of elasticity
present in the material. The material time can be given as
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τ=

1
ω tan(δ)

where ω is the oscillation frequency in rad/s.

From the stress and strain measured in the oscillation experiments, different parameters
can be calculated (figure 9.2) [85] as shown below.
1. Storage modulus (G')
The storage modulus or G' is the elastic stress to strain (in-phase) ratio. It describes the
amount of structure present in a material and its ability to store energy.
2. Loss modulus (G")
The loss modulus is the ratio of the viscous component of the material to the strain (outof-phase). It describes the material's ability to dissipate stress through heat.
3. Complex modulus (G*)
The complex modulus represents the overall resistance of the material to deformation and
is the sum of G' and G".
4. Loss factor (tan δ)
The loss factor provides the relative degree of energy dissipation or damping of the
material and is the ratio G′ /G".
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5. Complex viscosity (η*)
The complex viscosity measures the total resistance to flow and is given by the maximum
stress amplitude to the maximum strain amplitude ratio.
In terms of equations,

• G∗=

Stress∗
Strain

Stress∗

= G′ + iG"

• G′ = �
� cos δ
Strain
Stress∗

• G" = �
� sin δ
Strain
G"

• tan δ = � ′ �
G

• η′ =

• η" =

• η∗=

G′
ω

G"
ω

G∗
ω

= η′ + iη"

Equation 9.2: Storage, loss, and complex modulus, loss factor, complex viscosity
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Figure 9.2 Dynamic strain deformation and stress response [85].

9.3.2 Deborah number
Every material has a characteristic material time (mentioned in the previous
section). The material is considered a viscous liquid if the material time is shorter than
the observation time (or deformation time). The material time of water is 10 s; any
observation time seems larger, and we see the flow behavior. However, glass has a
material time of hundreds of years, and therefore we do not see its flow behavior. The
Deborah number (De) is the ratio of the material time to the observation time [83], [85],
[88]:
Ʌ

De = .
t

• If a rheological experiment is faster than the material time, the behavior is
primarily elastic, and vice-versa is true if the material time is smaller.
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• The material time depends on the composition of the material. Elastic forces act
over a characteristic time scale when the material is deformed.

• The De number provides insight into the material behavior over a given
timeframe.

• For elastic solids, Ʌ → ∞.
• For viscous liquids, t → ∞.
From Maxwell's model,
G′ = G Ʌ

ω
1 + (Ʌ ω)2

G" = G Ʌ

(Ʌ ω)2
1 + (Ʌ ω)2

Equation 9.3: Calculation of storage and loss modulus using Maxwell’s model.

where G is the shear modulus.
Therefore
Ʌ=

1 ′
G /G".
ω

Since

consequently,

De =

De =

Ʌ
= Ʌ x ˙γ,
t
1 ′
G /G" x ˙γ.
ω
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Finally, we obtain the equation
De =

1
x ˙γ.
ω tan(δ)

Equation 9.4: Calculation of De using the Maxwell’s model.

Based on the above information, we can classify the behavior of VE materials in the as
shown in table 9.1.
Table 9.1: Storage and loss modulus for different conditions
Condition

G” > G’

G” = G’

G" < G'

Phase

δ > 45°

δ = 45°

δ < 45°

Loss factor

tan δ > 1

tan δ = 1

tan δ < 1

Deborah number

De < 1

De = 1

De > 1

Material behavior

Primarily viscous

Perfectly VE

Primarily elastic

It should be noted that the above is valid for a given shear rate and oscillation frequency.
At greater oscillation frequencies, the G' increases. Moreover, at tan δ = 0°, the materials
behave like an elastic solid, and at tan δ = 90°, they behave like a viscous liquid.
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PART-B EXPERIMENTAL
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CHAPTER 10 DEVELOPMENTAL EXPERIMENTS FOR ADMINISTERING
LIPID OMBs IN AN ARDS RAT MODEL
Developing extra-pulmonary support therapies to provide oxygenation in
ARDS necessitates the creation of an injury model that closely mimics the
pathophysiology of ARDS in humans. Several studies have been reported on the utility of
ARDS injury models (Tables 5.1 and 5.2). These studies have reported oleic acid-,
lavage-, smoke-inhalation-, gastric acid aspiration-, and LPS-induced ARDS injuries and
are summarized in the literature section. We utilized an endotoxin injury model by
administering LPS in rats (over a 48 h duration). This model induces moderate to severe
hypoxia in rats and is helpful in testing oxygenation strategies. The primary emphasis of
using this model is on obtaining the arterial blood gas parameters, peripheral oxygen
saturation, survival analysis, and histological parameters before and after the
administration of OMBs via the IP route.

10.1 Experimental design
ARDS was chosen as the respiratory disease for our study due to its prevalence,
associated hypoxia, limited treatment options, and extensive use in small and large
animal models. Moreover, previously our research group has successfully induced and
validated ARDS in rats and rabbits [52], [53], [82], [89]. In our study, ARDS injury was
created using LPS. As mentioned previously, LPS is an endotoxin found in the cell
membrane of gram-negative Escherichia coli. It is a crucial component of the bacterial
cell membrane and plays a critical role in maintaining its health. Upon entering the body,
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LPS is recognized by the toll-like receptors (TLR) that set into motion a signaling
cascade that damages the endothelial cell layer of the capillaries surrounding the alveoli,
leading to edema and inflammation [40]. In the current study, 24 mg/kg LPS was
aerosolized into the rat trachea to inflict a direct-lung injury. The rat was then monitored
for PaO2, %SpO2, and weight loss to characterize disease progression. Catheters were
implanted into the femoral artery and the peritoneal cavity (PC). These surgeries were
carried out by Charles River (Wilmington, MA). The femoral artery catheter was used to
draw blood for ABG analysis, while the IP catheter was used to administer OMBs to the
PC. The femoral and IP catheters had a dead volume of 51.6 μL and 47.0 μL,
respectively. Both the catheters had an I.D. of 0.02” and an O.D. of 0.04”. Pinports were
placed on the catheter tips to prevent contamination, to ease blood withdrawal, and to
administer OMBs.
Baseline weight measurements were taken, followed by chest radiographs in the
dorsoventral and left-lateral positions. Following this step, LPS was administered to the
rats using an aerosolizer. ABG and PO were performed every 12 h, directly before and
after administering a 100 mL/kg OMB bolus. Chest radiographs were then performed
every 24 h. All the surviving rats were euthanized at the 48 h study endpoint.

10.2 Materials and methods
This section provides details on the different steps used to create the ARDS model
in rats and to administer OMBs via the PC. The statistical tests used to evaluate the study
parameters are also explained. All animal experiments for this study were performed per
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the University of Nebraska-Lincoln Animal Care and Use Committee (IACUC). For the
developmental experiments, 11 male Wistar rats weighing 300-500 g were purchased
from Charles River Laboratories (MA) and acclimated to the animal facility for 5 days
with free access to food and water. Following the acclimation period, rats were subjected
to LPS administration, followed by the administration of OMBs.

10.2.1 Administration of LPS via aerosolization
To administer LPS, the rats were first weighed to determine the quantity of LPS
required. LPS (Escherichia coli, O111:B4, L2630) was purchased from Sigma-Aldrich
(St. Louis, MO). The quantity of LPS required was calculated in the following manner:
a. The weights of all the rats were added to obtain msum.
msum =

b.

# of rats

� mi
i=1

½ of the average mass was added to msum to obtain mtotal.
mtotal =

1
m
+ msum
2 average

c. The quantity of LPS required was calculated from the mtotal (24 mg/kg dose of
LPS).
mLPS = 24 × mtotal

d. The mLPS amount of LPS was weighed into a vacutainer.
e. The volume of saline required to dissolve the LPS was calculated as (20 mg/mL
LPS).
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Vsaline =

mLPS
20

Following the calculation of LPS quantity, the appropriate volume of saline was taken
in a 50 mL glass bottle. Saline was heated to 90 °C for 5 min. on a magnetic stirrer at
240 rpm, followed by the addition of LPS. The solution was stirred again at 240 rpm
on a magnetic stirrer maintained at 90 °C for 15-20 min., or until the solution turned
pale yellow without any undissolved LPS flakes. The LPS solution was then
transferred to 1 mL glass syringes (Medallion, NY).
To administer LPS, the rats were sedated in an induction chamber using 5%
isoflurane (figure 10.1). When the rats’ muscles fully relaxed, they were removed
from the chamber and placed on a pad for chest radiography (PRX 90, Bowie
International LLC, Lake City, IA). At this point, sedation was maintained using a
nose cone by administering 2.5% isoflurane. Chest radiographs of the rats’ lungs
were obtained from the dorsoventral and left-lateral views. The head of the rats was
lifted by 3.0-3.5 cm at an angle of 45° to the horizontal. If necessary, an
oropharyngeal intubation wedge was placed in their mouth. A probe was used to
illuminate the vestibular folds to ease LPS administration (Anykit, Irvine, CA). The
LPS syringe was attached to a MicroSprayer® aerosolizer (Penn Century, out of
business now) (Figure 10.2). The MicroSprayer® was inserted through the mouth
until resistance was met with the carina. LPS was then aerosolized into the lungs
(figure 10.3).
After administration of LPS, the rats were periodically rotated to ensure even
distribution in the lungs until the rats regained consciousness. They were then
returned to their cages.
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Figure 10.1: Sedated rat in the induction chamber.

Figure 10.2: Aerosolizer for LPS administration.
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Figure 10.3: Schematic showing direct lung injury induced by aerosolization of LPS.

10.2.2 Sample collection
Upon administration of LPS, the rats were put back in the cages. At 12 h postLPS administration, first, the weight of the rats was obtained, followed by the sampling
of %SpO2 and ABG parameters (PaO2 and PaCO2). A total of six rats were used to test
the protocol, and only four received OMBs. For those that received OMBs, %SpO2 and
ABG parameters were obtained before, and 20 min. after the administration of OMBs. A
paw-clip sensor was used to determine the %SpO2. However, due to difficulties in
handling the rats, it was later replaced with a collar sensor that did not require them to be
restrained.
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10.2.2a Catheter maintenance
To maintain patency, the catheters were flushed every day with 0.1 mL of sterile
saline (VetOne, Boise, ID). The femoral catheter was then filled with 0.1 mL catheter loc
solution containing heparin (SAI-infusion, IL). The saline drains any blood in the catheter
while the heparin in the loc solution prevents the blood from clotting.

10.2.2b ABG analysis
ABG analysis uses an arterial or venous blood sample to determine the PaO2
(partial pressure of O2), PaCO2 (partial pressure of CO2), and blood pH. The ABG
analyzer also enables co-oximetry to determine %SaO2, FO2Hb, FCOHb, FMetHb,
FHHb, and acid-base analysis. The ABG analysis was performed using an ABL80-FLEX
CO-OX analyzer (Radiometer, Brea, California, USA). For our study, we used the
analyzer to mainly determine the PaO2 and PaCO2.
The rats were taken out of their cages and weighed (explained in the previous
section). Next, the pinports on the catheters were sterilized using an alcohol swab. To
access the pinport, an injector (PNP3M, Instech, Plymouth, PA) was attached to a 1 mL
syringe. The rats were restrained, and the syringe was attached to the pinport and secured.
The syringe plunger was gradually pulled to withdraw the catheter loc solution. The
solution was then discarded, and the syringe was attached again to withdraw 0.1 mL of
blood. The volume of blood withdrawn was less than 1% of the total blood volume of a
rat to avoid hemodynamic changes. The injector was removed, and the analyzer probe
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was inserted into the syringe. The sample was then analyzed. About 0.1 mL of saline was
then administered through the catheter, followed by the addition of the loc solution.

10.2.2c Pulse oximetry
The pulse oximetry (PO) provides the peripheral O2 saturation value or %SpO2.
The %SpO2 was determined to observe the detrimental effect of LPS on the lungs. As
mentioned in the literature section, LPS results in pulmonary edema that severely reduces
the diffusion of O2 from the alveoli to the blood. As a result, the PaO2 in the blood
declines and consequently the %SpO2. A paw-clip sensor pulse oximeter (PhysioSuite
MouseSTAT®, Kent Scientific Corporation, Torrington, CT) was initially used for PO.
The rats were first restrained, and the sensor was then attached to their hind paw. The
sensor was placed in multiple positions to determine the appropriate site for
measurement. Once placed, the measurements were monitored in 5 s averages and were
recorded every second when a consistent waveform was seen on the screen display. The
measurements were then averaged for 1 min. However, due to persistent difficulties
restraining the rats and potentially injuring their paw, the pulse oximeter was replaced
with another device with a collar clip sensor (MouseOx Plus®, STARR Life Sciences,
PA). Mouse Ox Plus® is specifically designed for awake rats and does not require the
rats to be restrained. Moreover, a study comparing MouseOx Plus® and MouseSTAT®
established the superior accuracy of the former. Therefore, MouseOx Plus® was used for
all future studies. Measurements were taken at a frequency of 15 readings/s (after
obtaining consistent waveforms) for one min. All the values were then averaged to
provide a single %SpO2 value for that time point.
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10.2.2d Chest radiography
Chest radiographs were obtained prior to the administration of LPS and, after that,
every 24 h. The rats were placed in an incubation chamber and sedated with 5%
isoflurane to obtain the radiographs. Once unresponsive to paw pinch, the rats were
placed on a pad. Sedation was maintained using 2% isoflurane administered via a
nosecone. The rats were radiographed in the dorsoventral and left-lateral positions. The
radiographs were used to observe the presence of the LPS irritant in the lungs and to look
for signs of edema and bilateral infiltrates. The rats were placed in their cages after the
radiography was completed and were monitored until they regained consciousness.

10.3 Synthesis and administration of OMBs
The OMBs were provided by the Borden research lab at CU-Boulder. For the
developmental experiments, DSPC (C18:0) OMBs were provided. Phospholipids (DSPC,
DBPC, and DPPC) were purchased from Avanti polar lipids (Birmingham, AL). The 1,2distearoyl-sn-glycero-3-phosphoethanolamine (DSPE-PEG2000) was purchased from
NOF (Tokyo, Japan). The phospholipids and DSPE-PEG2000 were weighed in dried
form, combined to a 9:1 molar ratio, and dissolved into a 0.2 µm filtered solution of 0.15
M phosphate-buffered saline (PBS) to a final lipid concentration of 10 mg/mL. Next, the
lipid mixture was heated to 65 °C and then dispersed in a sonifier (Branson 450,
Danbury, CT) until the resulting solution was translucent. The solution was then
refrigerated prior to the synthesis of OMBs. In the next step, the lipid suspension was
combined with O2 (maintained at room temperature) and fed to an ultrasonic horn reactor
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enclosed in a water-cooler, continuous flow chamber (Branson, Danbury, CT) at 5 °C.
The O2 was then emulsified at full sonication and subsequently fed to a flotation column
to separate the OMBs at the bottom of the column from the macrofoam at the top. The
OMBs were then isolated in a syringe by centrifuging (Eppendorf, Hauppauge, NY) at
130 rcf for 3 min. The OMB foam was then stored in 500-mL serum vials (Wheaton,
Pasadena, TX). The OMBs were shipped in sealed glass vials and stored at 4-8 °C prior
to use. Since the OMB core contains 100% O2 and is surrounded by a lipid membrane
that is permeable to O2 diffusion, the exposure of O2 to the atmosphere provides a
pressure gradient for the diffusion to occur. As a result, the OMBs release O2 and shrink
in size. To avoid this event from occurring, the exposure of OMBs to the atmosphere was
kept minimal.
Prior to administering OMBs, the rats were weighed. Based on a 100 mL/kg
OMB dose, the required volume of OMBs for the rats was calculated. By holding the
neck of the bottle to allow for proper mixing, the OMB vial was gently swirled for 1-2
min., or until the suspension appeared homogenous. Two 18 Ga, 8” needles were inserted
through the diaphragm vial. One of the needles allowed for the flow of O2, while the
other was used as a vent (figure 10.4). On one of them, a luer cap was attached while the
other needle was attached to a three-way luer valve connector (Qosina, NY) that was
connected to an O2 supply via a 3/16” silicone tube (Qosina, NY). The 3/16” tubing was
connected to a 1/8” tubing (Qosina, NY) with a 1/8” barbed-male luer lock connector
(Qosina, NY). The luer cap on the vent needle was detached, and the three-way luer valve
connector on the O2 needle was opened. The headspace of the vial was then primed with
O2 by holding the vial upside down and allowing the O2 to flow to the vial at 2 L/min.
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for 1 min. The flow rate was then reduced to 1 L/min. During the headspace priming, the
tip of the needles was always in the headspace (empty, not surrounded by OMBs). A oneway stopcock (Qosina, NY) was attached to a 30 mL syringe. An 18 Ga 5/8” needle was
then used to withdraw the OMBs. The syringe was attached to the vial. The OMBs were
withdrawn by pulling the plunger (~1 mL/s). Upon withdrawing the required volume, the
syringe valve was closed, and the syringe was removed. The vial was resealed by
smoothening the silicone gel and refrigerated. The OMB syringe was then attached to a
pinport injector and connected to the IP catheter (figure G.1). The plunger was pushed to
administer OMBs at ~1 mL/s by gently restraining the rat.
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Figure 10.4: Lipid-coated OMBs [4]. (a) Oxygen gas comprises 99% of the microbubble volume. The
oxygen core is stabilized by a thin (~3 nm) phospholipid monolayer membrane. A hydrated PEG brush
(~10 nm height) grafted to the lipid surface provides steric repulsion to prevent microbubble
coalescence. (b) A scaled-up OMB manufacturing process. (c) Bright-field microscopy of diluted OMBs
showed discrete, spherical microbubbles. (d) OMBs have a milky white appearance and can be stored
and transported in 500-mL serum vials. (e) Volume and number weighted size distributions for freshly
generated OMBs. The dashed lines are the number (blue) and volume (red) mean diameters. The shaded
area covers the size range for 90% of the total OMB gas volume.
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Figure 10.5: Handling and priming the headspace of OMB vial for OMB withdrawal.

10.4 Statistics
All the data (except survival) was first tested for normality. A one-way ANOVA
test was performed using ordinary ANOVA (equal SD) or Brown-Forsythe and Welch
ANOVA (unequal SD) if the data was normal. If the data was not normal, a nonparametric test was used. Further, Tukey’s (for ordinary ANOVA) or Dunn’s multiple
tests (non-parametric test) were used to perform multiple comparisons on the groups. The
survival data were analyzed using the Log-rank (Mantel-Cox) test to compare the
mortality between the different groups. For the developmental experiments, no statistical
analyses were performed. However, the main study utilized the statistical tests mentioned
above. All the data were analyzed and plotted using the GraphPad Prism software (San
Diego, CA). An α < 0.05 was considered significant.
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10.5 Results
The developmental experiments were focused on replicating and revalidating the
ARDS model in rats following the previous studies conducted by our research group.
However, in this phase, several problems were encountered upon using the paw clip
sensor for PO. We also encountered issues with the ABG analyzer and administration of
OMBs.

10.5.1 Pulse oximetry
After the administration of LPS, the rats were visibly weak, struggling to breathe,
and had a reduced food and water intake. These signs point towards the onset of ARDS..
The % SpO2 of the control rat (OMBs could not be administered) at 12 h post-LPS was
86%. This value declined to 81% at the 24 h time point and increased to 87% later. The
rat displayed moderate-to-severe hypoxia and died after 36 h. For the OMB group,
several problems were encountered while administering the OMBs due to heavy
resistance from the syringe plunger while administering the OMBs. This issue was
determined to be due to the sectioned end of the distal tip of the IP catheter that reduced
the cross-section for the flow of OMBs. For subsequent studies, the distal tip of the
catheter was clipped by the Charles River surgical team. The %SpO2 of the rats declined
after the first OMB treatment. A slight improvement was seen after the second treatment,
after which the %SpO2 further declined at the 36 h timepoint. However, it should be
noted that the paw clip sensor displayed inconsistent waveforms. The %SpO2 values are
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shown in table 10.1. Statistical analyses were not performed due to the several issues
encountered while measuring the %SpO2 and PaO2.
Table 10.1: %SpO2 of the rats (OMB group) at the different experimental timelines
12 h pre-OMB

12 h post-

24 h pre-OMB

24 h post-

36 h pre-OMB

n=5

OMB
n=5

n=2

OMB
n=2

n=3

92.1 ± 5.7

83.2 ± 16.5

94.2 ± 3.7

94.1 ± 4.5

86.2 ± 8.2

10.5.2 Blood gas analysis
Due to persistent issues with the analyzer, the ABG analysis was performed
intermittently on the rats across the different time points after troubleshooting. Towards
the end of the development phase, the analyzer issues were fixed for the main study.
However, among the rats undergoing ABG analysis, the PaO2 (mm Hg) increased by 7.0
± 4.9 mm Hg after the first treatment and 6 mm Hg after the second treatment.

Table 10.2: PaO2 (mm Hg) of the rats (OMB group) at the different experimental
timelines
12 h pre-OMB

12 h post-

24 h pre-OMB

OMB

24 h post-

36 h pre-OMB

OMB

n=2

n=2

n=1

n=1

n=1

94.5 ± 4.9

101.5 ± 0.7

93.0

99.0

139.0
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10.5.3 Chest radiographs
The chest radiographs of the rats were taken every 24 h to evaluate the
pathognomonic signs of ARDS in the lungs (figure 10.5). The radiographs were
examined for pulmonary edema, alveolar consolidation, and bilateral infiltrates. For the
developmental phase, an additional chest radiograph was taken immediately after
administration to ensure the presence of LPS in the lungs. For this phase, the chest
radiographs of the other rats were lost due to issues with the computer system connected
to the X-ray machine at the life science annex at UNL.
Rat- 1
12 h (pre-OMB)

Rat-1
12 h (post-OMB)

Rat-2
12 h (pre- OMB)

Rat-2
12 h (post-OMB)

Figure 10.6: Chest radiographs in the dorsoventral (DV) positions at 12 h post-OMB for all rats.

10.5.4 Survival rate
Since one rat did not receive OMBs, it was used as a control rat. The KaplanMeier survival plot for the rats is shown in figure 10.6. The control rat was found dead at
36 h post-LPS insult. In the OMB group, eleven rats received at least one bolus of OMB.
Three rats were found dead at the 36 h post-LPS, and eight survived until the end of the
study. The survival rate of rats in the OMB group was 72.7%.
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Figure 10.7: Kaplan-Meier plot showing survival of rats

10.6 Discussion
The developmental phase of the study was performed to replicate and revalidate
the ARDS model that was previously used by our research group. Our study chose to test
OMBs via the IP route on an ARDS rat model. In this model, ARDS was induced in the
rats by aerosolization of LPS at a 24 mg/kg dose. After the administration of LPS, the rats
were visibly sick with reduced food and water intake, lethargic movement, and signs of
breathing difficulty, thus displaying signs of ARDS. Chest radiographs were taken
before and after LPS administration to confirm the presence of LPS in the lungs.
Thereafter, chest radiographs were taken every 24 h., while PO and ABG analysis was
performed every 12 h— before and directly after OMB administration. The weight of the
rats was taken every 12 h. In this phase, we encountered several issues related to ABG
analysis. The paw clip sensor proved to be unsuitable for PO for the next study phase due
to inconsistent SpO2 waveforms and other issues caused by the restraining of rats. There
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were difficulties in keeping the rat paw still while attaching the sensor. Moreover, the rats
had to be restrained for longer durations, which caused them visible discomfort. We
purchased a pulse oximeter with a collar clip sensor suitable for monitoring awake
subjects to circumvent this problem. The sensor was attached to the neck of the rat
without needing to restrain it and allowed for continuous monitoring of the %SpO2 at
high sampling frequencies. The collar sensor was used for the remainder of the study.
The rats used in this study arrived with implanted catheters having pinport access. We
initially faced difficulties in maintaining the patency of the catheters, due to which some
of them could not be used to sample blood. With appropriate troubleshooting, this
problem was resolved. Among the rats with patent catheters, the PaO2 increased by 7.0 ±
4.9 mm Hg after the first treatment and 6 mm Hg after the second treatment. At the 48 h
time point. The SpO2 dropped by 8.9 ± 17.4% after the first treatment and 0.1 ± 5.8%
after the second treatment. The mean SpO2 at the 36 h time point was 86.2 ± 8.2%. The
mean SpO2 at 12 h showed mild hypoxia. The O2 levels in the blood increased after the
administration of OMBs. However, the SpO2 did not follow the same trend. Eight out of
eleven rats in the OMB group survived until the study endpoint of 48 h, showing a
survival rate of 72.7%.

10.7 Conclusions
Intratracheal aerosolization of 24 mg/kg LPS induced ARDS in rats by rendering
them hypoxic. The rats suffered mild-to-moderate hypoxia. Administration of OMBs
increased the PaO2, but the mean SpO2 did not show a similar increase. The survival of
rats in the OMB group was 72.7%.
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CHAPTER 11 INVESTIGATING THE INDIVIDUAL EFFECTIVENESS OF
OMBs WITH DIFFERENT SHELL TYPES IN IMPROVING THE SURVIVAL
OF RATS WITH LPS-INDUCED ARDS
In the developmental phase study (chapter 10), 24 mg/kg LPS was successfully
used in inducing ARDS in rats. Previously, Fiala et al. performed a similar study on rats
with ARDS to test DSPC OMBs via IP administration [53]. However, the catheters used
in that study were not provided with pinports. Similar to our developmental experiments,
Fiala et al. reported mild-to-moderate hypoxia in rats when 24 mg/kg LPS was
administered intratracheally [53]. In that study, the survival of rats receiving OMBs was
80%. This chapter compares the results of testing DSPC-, DBPC-, and DPPC- shell
OMBs on rats with ARDS. The DSPC, DBPC, and DPPC lipids have carbon chains with
18, 22, and 16 carbon atoms, respectively (figure 11.1).
Kim et al. showed that increasing the acyl chain length of lipids leads to increases
in the yield stress and the viscosity [78]. Moreover, the chain length increases the Van
Der Waals forces between the lipid molecules and makes the shell rigid due to
cohesiveness [76]. As a result, the shell resistance to gas diffusion increases with the
increase in the length of the lipid chain. Therefore, it can be expected that OMB shells
with longer lipid chains impart greater resistance to O2 diffusion. Lipids with longer
chains tend to be stable due to the cohesiveness between the lipid molecules, vice-versa is
true for shorter chains. However, lipids with smaller chains can be unstable.
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a

b

c

Figure 11.1: Chemical structure of (a) DSPC, (b) DBPC, and (c) DPPC lipids showing the -CH2- bonds
represented by the straight lines. The lines represent -CH2- bonds.

11.1 Experimental design
For this study, rats were purchased from Charles River and were delivered with
implanted femoral and IP catheters with pinports. Following the new NIH guidelines,
equal numbers of male and female rats were used. The male and female rats weighed
between 300-500 g. For the study, 10 rats (5 males and 5 females) were purchased from
Charles River Laboratories for each of the lipid formulation. To optimize resources and
efficiently perform all the steps in the study protocol, males and females were ordered on
alternate weeks.
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11.2 Materials and methods
All the animal studies were performed in accordance with the IACUC-UNL
guidelines. The experimental timeline is shown in figure 11.2. All the rats arrived with
femoral artery catheters and IP catheters with dead volumes of 51.6 μL and 47.0 μL,
respectively. The rats were acclimated to the animal facility for 5 days with free access to
food and water. The femoral artery catheter was flushed with 0.1 mL saline every day
and filled with 0.06 mL heparinized glycerol loc solution to maintain catheter patency.
The IP catheter was only flushed with 0.1 mL saline. A 1 mL syringe was attached to a
pinport injector and then connected to the catheter. The plunger was slowly pulled to
withdraw the old loc solution. A new syringe was used for flushing saline followed by the
loc solution. Catheter maintenance is essential to maintain catheter patency for blood
draws.
Post-acclimation, the rats were weighed. The amount of LPS required was
determined by the weight of the rat. A 24 mg/kg dose of LPS was used. After calculating
the weights of rats, the required amount of LPS (Escherichia coli, O111:B4, L2630,
Sigma-Aldrich, St. Louis, MO) was taken and dissolved in a certain volume of saline as
described in chapter 10. The LPS solution was refrigerated until further use. To
administer LPS, the rats were first sedated using 5% isoflurane, and sedation was
maintained with 2.5% isoflurane. The rat's head was lifted by 3.0-3.5 cm. An aerosolizer
(MicroSprayer® Aerosolizer IA-1B-R, Penn Century) was attached to a 1 mL syringe
containing LPS solution. The LPS was administered in the trachea in the manner
described in the previous section. The rats were rotated to distribute LPS evenly in the
lungs.
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Chest radiographs of the rats were taken in the dorsoventral and left-lateral
positions, before administering LPS and every 24 h after that. The rats were sedated to
obtain chest radiographs and later put back in the cages and monitored until they regained
consciousness. At 12 h post-LPS, the rats were prepared for OMB administration. The
rats were first monitored for visible signs of ARDS sickness. Next, they were weighed to
determine the volume of OMBs to be administered. Blood draws were performed on the
rats using the femoral catheter, and ABG analysis was then performed. Next, the %SpO2
of the rats was determined using the collar sensor. The OMBs were withdrawn in a 30
mL syringe. Before withdrawing the OMBs, the vial was swirled to mix the contents. The
OMBs were withdrawn in the manner explained in the previous chapter. The rats were
then administered OMBs at a 100 mL/kg dose via the IP catheter. For administration, the
syringe was attached to the IP catheter via the pinport injector, and the plunger was
slowly pulled to administer OMBs at ~1 mL/s flowrate. Post-OMB administration, the
rats were rested in the cage for 20 min. and PO and ABG analysis was performed. A
second blood sample was obtained in the event of air contamination in the first one. Upon
completing the studies, the rats were put back in their cages. The above steps were
repeated every 12 h, up to 36 h.
At the 48 h study endpoint, ABG analysis and PO was performed on all the
surviving rats, followed by chest radiography. The rats were then humanely euthanized
by placing them in an incubation chamber and administering CO2. Once the rats were
unresponsive, their carcasses were placed on the surgery table for necropsy. An incision
was made in their abdomen to gain access to the diaphragm. After incising the
diaphragm, the lungs were visible. The tracheobronchial tree was excised along with the

100

lungs. The trachea was clamped while the connective tissue and the heart were separated
from the lungs. The lung surface was cleaned to remove the blood and was photographed.
The left lung was excised and used for the wet/dry ratio, while the right lung was used for
histological analyses. The wet weight of the lungs was measured immediately. The lung
samples were then placed in an oven (20GC Analog Lab Oven, Quincy Lab, Chicago, IL)
for three days at 60 °C. The dry weight was determined on the third day by reweighing
the dried lung [90]. The wet/dry ratio was calculated by dividing the two weights.
After excising the right lung, 3 mL of 10% buffered formalin (575A-1GL,
Medical Chemical, Torrance, CA) was used to inflate the lobes of the right lung. The
lung was then suspended in a container with 10% formalin and stored until histology.
The right lungs were submitted to an independent pathologist at the veterinary diagnostic
center at UNL for histological scoring. The pathologist performed blind sectioning,
hematoxylin and eosin (H&E) staining (Ventana Symphony, Ventana Medical Systems,
Inc., Tucson, AZ), and injury scoring using the method of Erdem et al. [91]. The lung
sections were imaged with a microscope (Eclipse 55i, Nikon Instruments, Melville, NY)
at 100X magnification after the H&E staining. Each lung section was scored for edema,
hemorrhage, and inflammation and assigned a score of 0-3 depending on the severity. A
score of 0 represented normal tissue. A score of 1 represented mild pathological changes
characterized by edema or hemorrhage within 5-10% of the lung or an influx of fewer
than 10 leukocytes per 100X field of view. A score of 2 indicated moderate pathological
changes with edema or hemorrhage affecting 10-20% of the lung or 10-45 leukocytes per
field of view. A score of 3 represented severe pathological changes with edema or
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hemorrhage affecting greater than 20% of the lung or an influx of more than 45
leukocytes per field of view.

Figure 11.2: Experimental timeline.

11.2.1 Statistics
All the data (PO, ABG, histology) were first analyzed for normality. If the data
were normal, an ordinary one-way ANOVA was performed (equal SD) or a BrownForsythe and Welch ANOVA (unequal SD). If the data was not normal, a non-parametric
test was performed. Further, Tukey’s (for ordinary ANOVA) or Dunn’s multiple tests
(non-parametric test) were used to perform multiple comparisons on the groups. The
survival data were analyzed using the Log-rank (Mantel-Cox) test to compare the
mortality between the different groups. All the data were analyzed and plotted using the
GraphPad Prism software (San Diego, CA). An α < 0.05 was considered significant. The
differences in the various parameters were not significant unless specified.

11.3 Results
The results of this study included analysis of %SpO2, PaO2, histological scores
(edema, hemorrhage, and inflammation), and survival rates. One rat was dropped from
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the DSPC OMB group due to an adverse event. The chest radiographs of the rats are
shown in appendix B, C, and D.

11.3.1 Blood gas analysis
All the rats displayed visible signs of sickness— reduced activity, loss of weight,
respiratory difficulty, and reduced or no food and water intake— indicating ARDS onset.

11.3.1a DSPC OMBs
Blood gas analysis was performed along with PO before administering OMBs and
directly after it. Despite increases in the PaO2 of some rats after administering the 1st
OMB bolus, the mean PaO2 in the group had decreased at 20 min. after it (figure 11.3).
The pre-treatment value was 78.0 ± 12.5 mm Hg, while the post-treatment value was 68.3
± 15.4. However, the PaO2 value after administering the 2nd OMB bolus had increased
from 68.6 ± 14.9 mm Hg to 72.5 ± 9.6 mm Hg. There was a slight increase in the PaO2
after the 3rd OMB bolus, wherein the PaO2 mildly increased from 68.6 ± 13.3 mm Hg to
69.0 ± 10.7 mm Hg. The PaO2 at the study endpoint was 73.0 ± 11.6 mm Hg. The mean
PaO2 had increased after the 2nd and the 3rd treatment. The mean PaO2 at the study
endpoint (73.0 ± 11.6 mm Hg) was higher than that at the 36 h time point (68.6 ± 13.3
mm Hg), showing an increase in oxygenation.
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11.3.1b DBPC OMBs
The PaO2 values of rats at the 12 h time point in the DBPC OMB group were in
the range of 60 – 132 mm Hg (figure 11.3). Nine out of ten rats had PaO2 values below
79 mm Hg. However, there was one outlier with a PaO2 of 132 mm Hg. The ABG
analysis was repeated for this rat by doing a second draw due to a possible air
contamination, but the PaO2 value remained the same. The reason for such a high value
compared to others is not known. The mean PaO2 before OMB administration was 75.6 ±
20.8 mm Hg and 68.2 ± 10.5 mm Hg after it. The PaO2 further declined to 63.0 ± 12.4
mm Hg at 24 h post-LPS administration and increased to 66.7 ± 11.7 mm Hg after
administering OMBs. Six rats died between 24 h and 36 h due to the low PaO2 and
SpO2. At 36 h after LPS administration, the mean PaO2 of the three surviving rats was
49.3 ± 12.9 mm Hg and increased to 59.33 ± 20.2 mm Hg after administration of OMBs.
At the study endpoint, another rat died, leaving only two surviving. The mean PaO2 of
the surviving rats was 60 ± 11.3 mm Hg. Increases in the PaO2 were seen at 24 h and 36
h post-OMB administration. Although some rats showed increases in the PaO2, the other
rats did not. The mean PaO2 decreased continuously and possibly led to the high
mortality

11.3.1c DPPC OMBs
At 12 h post-LPS administration, the mean PaO2 of the rats had increased
marginally in the DPPC OMB group. The mean PaO2 before OMB administration was
78.2 ± 12.8 mm Hg and 78.7 ± 14.7 mm Hg after the administration (figure 11.3). Four
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rats died by the 24 h time point. The mean PaO2 of the surviving animals at 24 h was
72.7 ± 25.0 mm Hg, not significantly different from the post-OMB PaO2 of 72.8 ± 25.0
mm Hg. The mean PaO2 declined continuously. At 36 h, only 4 rats survived and had a
mean pre-OMB PaO2 of 56.5 ± 22.9 mm Hg and a post-OMB PaO2 of 58.0 ± 22.3 mm
Hg showing the largest increase in PaO2 compared to the other time points. However,
this increase was not sustained as only 1 rat survived until the study endpoint. The
surviving rat had a PaO2 of 74.0 mm Hg.

Figure 11.3: Comparison of the PO2 (mm Hg) pre-, and post-DSPC, DBPC, and DPPC OMBs at different
time points post-LPS administration. The DSPC, DBPC, and DPPC lipids have been abbreviated as L1, L2, L3
(lipid-1,2,3), respectively.

11.3.2 Pulse oximetry
Occasionally, the rats’ movement detached the collar sensor. In such an event, the
SpO2 reading was discarded, the collar clip was reattached, and the measurement was
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repeated. The SpO2 was determined by averaging values over 1 min., at a frequency of
15 readings/s. After attaching the sensor, values were recorded only after obtaining
consistent pulse waveforms.

11.3.2a DSPC OMBs
In this group, at the 12 h interval, the mean SpO2 was 88.6 ± 5.7%, indicating
mild hypoxia (figure 11.4). Among all the rats, two showed moderate hypoxia with SpO2
of 81.9% and 77.4%. After the 1st OMB treatment, the mean SpO2 was 88.17 ± 5.8% and
was not significantly different from the pre-OMB SpO2 of 88.6 ± 5.7%. However, some
of the rats (individually) showed increases in the SpO2 in the range of 0.6-9.0%. The
mean SpO2 at 24 h was 92.3 ± 3.8% before the 2nd treatment and 91.9 ± 2.6% 20 min.
after it. Similarly, the mean SpO2 at 36 h was 90.7 ± 6.9% before the 3rd treatment and
88.2 ± 9.3%. In both these cases, individual increases in the SpO2 were seen after OMB
administration, but the mean SpO2 did not increase significantly. At the study endpoint
(48 h), the mean SpO2 was 92.7 ± 2.7%.

11.3.2b DBPC OMBs
In the DBPC OMB group, the mean SpO2 at 12 h post-LPS administration was
89.5 ± 27.2% prior to administering OMBs, and 89.5 ± 5.4% after the OMBs were
administered (figure 11.4). Overall, the rats showed moderate hypoxia. However, one of
the rats was severely hypoxic with a SpO2 of 77.4%. Most of the rats in this group had
SpO2 values in the range of 87.2-94.9%. The SpO2 further dropped to 83.8 ± 6.5% at the
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24 h time point, and the mean SpO2 did not show improvement at 20 min. post-OMB
administration (83.7 ± 8.3%). The SpO2 continued to fall until 36 h post-LPS
administration. The SpO2 declined to 80.0 ± 17.6% before administering OMBs at 36 h
and further declined to 77.9 ± 22.2% after it. However, several rats died at different time
points starting from 24 h due to the crashing SpO2. Only two rats survived until the study
endpoint and had a mean SpO2 of 88.1 ± 1.8%.

11.3.2c DPPC OMBs
In the DPPC OMB group, the mean SpO2 at 12 h post-LPS administration
decreased from a pre-OMB value of 91.79 ± 3.9% to 91.1 ± 3.6% post-OMB showing
mild hypoxia (figure 11.4). A total of six rats died between 12 h and 24 h. The SpO2 also
showed a decreasing trend and crashed for some rats overnight. At 24 h, the mean SpO2
of the surviving rats was 86.2 ± 7.4% before OMB administration and 86.4 ± 8.2% after
it. Overall, the rats remained hypoxic. The hypoxia category shifted from mild to severe
at 36 h, with the mean SpO2 (pre-OMB) dropping to 72.8 ± 17.4%. Further, the SpO2
dropped again to 70.5 ± 18.2% after administering OMBs. The surviving rat at 48 h had
an SpO2 of 80.9%. These results show that the severity of hypoxia continuously
increased leading to mortality. The declining SpO2 and PaO2 contributed to the overall
mortality.
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Figure 11.4: Comparison of the %SpO2 pre-, and post-DSPC, DBPC, and DPPC OMBs at different time points
post-LPS administration.

11.3.3 Survival outcome
11.3.3a DSPC OMBs
Overall, towards the end of the study, the SpO2 remained higher than the
respective values at 12 h. This outcome was reflected in the survival of the rats. In this
phase, 2 out of 9 rats died before the study endpoint, leading to a mortality of 22.2% and
a consequent survival rate of 77.8% (figure 11.5). One of the rats died at 36 h post-LPS
while the other at 48 h post-LPS. Moreover, the surviving rats showed improved physical
activity and breathing rate after 48 h.
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11.3.3b DBPC OMBs
The PaO2 and SpO2 values continuously decreased overall despite increases in
some rats. The rats appeared sicker as more time elapsed after LPS, indicating
progression of ARDS. As can be seen from the SpO2 values, the ARDS conditions
shifted from mild at 12 h post LPS to moderate (and severe in some rats) as the study
proceeded (figure 11.5). As a result, several rats succumbed to the injury. Only 2 out of
the 10 rats survived (20% survival) in this phase compared to the 77.2% survival in
phase-1. The surviving rats were mildly hypoxic.

11.3.3c DPPC OMBs
The PaO2 and SpO2 results showed an increasing severity of hypoxia that
exacerbated the ARDS conditions in the rats despite OMB administration (figure 11.5).
As a result, the rats succumbed. Overall, only 1 rat survived in this phase leading to high
mortality of 90%, compared to 80% in phase-2 (DBPC) and only 22.3% in phase-1
(DSPC). The OMBs did not provide any survival benefit to the rats.
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Figure 11.5: Kaplan-Meier plot to compare the survival of rats in the DSPC, DBPC, and DPPC OMBs
administration groups.

11.3.4 Histological score and wet/dry ratios
11.3.4a DSPC OMBs
All surviving rats were euthanized at the 48 h study endpoint, and histology was
performed on the right lung. The histological images were observed at 100X
magnification and scored by an independent pathologist. The edema, hemorrhage, and
inflammation scores of the rats in the DSPC group were 0.4 ± 0.2, 0.7 ± 1.0, and 1.7 ±
1.1, respectively (figure 11.6-11.8). A representative histological image of one of the
lung samples from this group is shown in figure 11.10a. The scale bar shows a length of
100 µm. The image did not show signs of edema and had a score of ‘0’. The image
showed mild hemorrhage and had a score of ‘1’. The score for inflammation was ‘1’ due
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to mild inflammation. Most of the lung samples (right lung) had a score of 0 for edema,
with only two lungs with a score of 1. These results show that pulmonary edema was not
severe in the rats from phase-1. Moreover, one lung had severe hemorrhage with a score
of 3, while others had a mild hemorrhage or no hemorrhage. However, 7 out of 9 lung
samples showed mild to severe inflammation. The mean wet/dry ratio of the left lungs
was 5.7 ± 1.2 (figure 11.9).

11.3.4b DBPC OMBs
The edema, hemorrhage, and inflammation scores of the lung samples in this
group were 0.7 ± 0.5, 0.2 ± 0.5, and 2.4 ± 0.5, respectively (figure 11.6-11.8). Figure
11.10b shows a representative histological image with a scale bar of 100 μm, and a gross
lung image. The image showed mild edema with a score of ‘1’, mild hemorrhage with a
score of ‘1’, and severe inflammation with a score of ‘3’. All the lung samples (right
lung) from this phase showed mild-to-severe inflammation, as evidenced by the
inflammation scores. Moreover, only two lung samples did not show signs of edema,
whereas the others showed mild edema. The mean wet/dry ratio was 6.8 ± 1.0, indicating
the severity of pulmonary edema. The individual wet/dry ratios were in the range of 5.2 –
8.4 (figure 11.9).

11.3.4c DPPC OMBs
Histological examination of the right lungs of the rats in this group showed mildto-moderate edema in all the lung samples with a score of 1.5 ± 0.5 (figure 11.6). The
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hemorrhage and inflammation scores were 0.7 ± 0.8 and 2.4 ± 0.5, respectively (figures
11.7 and 11.8). All the lung samples showed moderate-to-severe inflammation. However,
some lung samples showed no signs of hemorrhage (n = 5), explaining the low score. The
wet/dry ratios were calculated to be in a range of 5.0 – 8.1, with a mean ratio of 6.7 ± 1.0,
showing the severity of pulmonary edema (figure 11.9). Figure 11.10c shows a
representative histological image with a scale bar of 100 μm, and a gross lung image.

Figure 11.6: Comparison of the edema scores of rat lungs in the DSPC, DBPC, and DPPC OMBs
administration groups.
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Figure 11.7: Comparison of the hemorrhage scores of rat lungs in the DSPC, DBPC, and DPPC
OMBs administration groups (P > 0.99).

Figure 11.8: Comparison of the inflammation scores of rat lungs in the DSPC, DBPC, and DPPC
OMBs administration groups.
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Figure 11.9: Comparison of the wet/dry ratios of rat lungs in the DSPC, DBPC, and DPPC OMBs
administration groups.

aa

bb

cc

Figure 11.10: Representative H & E histological sections of the rats’ excised lungs (top row) and gross
images of lungs (bottom row) in the (a) DSPC, (b) DBPC, and (c) DPPC OMB administration groups.
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11.4 Discussion
Overall, the SpO2 and PaO2 of rats in the DSPC group showed values
consistently greater than 82% and 68 mm Hg, respectively (figures 11.6 and 11.7). The
SpO2 and PaO2 of rats in the DSPC group did not continuously decrease across the
different time points. In contrast, the PaO2 and SpO2 of rats in the DBPC and DPPC
groups decreased throughout the study despite the administration of OMBs. The SpO2
did not improve even after administering the third OMB bolus. The SpO2 of rats in the
DBPC group dropped to 75%, while the SpO2 of rats in the DPPC group dropped to 70%
at the study endpoint (48 h). The PaO2 values of rats in the DSPC group remained above
68 mm Hg after 12 h of LPS administration. However, the PaO2 values of rats dropped to
50 mm Hg in the DBPC group and to 55 mm Hg in the DPPC group at the study
endpoint. Overall, the SpO2 and PaO2 of rats in the DSPC group was greater than those
in the DBPC and DPPC groups at any given time point after the OMB administrations.
The edema score in the DSPC group was significantly lower than that of the
DPPC group (P = 0.0003). However, the edema score between the DSPC and DBPC
groups did not reach statistical significance (P = 0.30) despite the DSPC group showing a
lower mean value. There were no statistical differences between the edema scores of the
DBPC and DPPC groups (P = 0.11). These results show that rats receiving DSPC OMBs
had a lower edema buildup in the lungs. The hemorrhage scores did not follow the trend
seen in the edema scores. None of the group comparisons (DSPC vs DBPC, P > 0.99;
DSPC vs DPPC, P > 0.99; DBPC vs DPPC, P > 0.67) showed statistical differences. The
mean hemorrhage score in the DSPC and DPPC groups was greater than the DBPC
group. In the DSPC groups, only 2 out of the 9 rats showed mild hemorrhage (score of 1).
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However, one rat showed severe hemorrhage (score of 3). The rats in all the OMB groups
showed moderate to severe inflammation with scores of 1.7 ± 1.1, 2.4 ± 0.5, and 2.4 ± 0.5
in DSPC, DBPC, and DPPC shells, respectively. Although the inflammation scores were
lower in the DSPC group, the difference was not statistically significant compared to the
other groups (P > 0.99).
The wet/dry ratios of lung samples in the DSPC group were lower than in the
DBPC (P = 0.08) and DPPC groups (P = 0.13), but the differences did not reach
statistical significance. Combined with the histology scores, these results show that the
buildup of pulmonary edema was less severe in the rats that received DSPC OMBs as the
wet/dry ratios and the edema scores were lower. The inflammation was lower in the rats
that were given DSPC OMBs. However, for hemorrhage, only one rat in the DSPC group
showed a score of 3, while others showed mild or no hemorrhage. These results indicate
that the ARDS injury in the rats was less severe when they were administered DSPC
OMBs.
The survival data for the rats were analyzed for differences using the Log-rank
(Mantel-Cox) test. Compared to the DSPC group (survival of 77.2%), the DBPC group
had a survival rate of only 20% (P = 0.0018), while the DPPC group had a survival of
only 10% (P = 0.0057). The survival of rats in the DBPC and DPPC groups was not
statistically different. These results show that administration of DSPC OMBs to rats with
ARDS led to a significantly greater survival than DBPC or DPPC OMBs. The DSPC
OMBs offered a greater survival advantage to the rats. These results agree with the
histology and wet/dry ratio results since ARDS severity affects the lungs leading to
hypoxic conditions that can ultimately lead to mortality. The edema scores and wet/dry
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ratios of rats in the DSPC group were lower than in the other groups. These results show
that in the rats with ARDS, the administration of DSPC OMBs decreased the ARDS
severity leading to greater survival.

11.5 Conclusion
Administration of DSPC shell OMBs imparted a greater survival to rats than the
DBPC or DPPC OMBs and were therefore more effective in improving the survival
outcomes. The resulting SpO2 and PaO2 values at a particular time point were always
greater for the DSPC group rats after the 12 h timepoint. The rats in the DSPC OMB
group showed less ARDS severity than the other groups.
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CHAPTER 12 DEVELOPMENTAL EXPERIMENTS FOR RHEOMETRY
MEASUREMENTS TO CHARACTERIZE THE VISCOUS AND VISCOELASTIC
BEHAVIOR OF OMBs
Lipids of different acyl chain lengths can be used to synthesize the shell for
OMBs. The shell stabilizes the OMBs by encapsulating gas in its core [73]. With an
increase in the number of molecules in the lipid chain, the rigidity of the lipid shell
increases due to an increase in the cohesiveness between the molecules, resulting from
Van der Waal’s forces. Therefore, lipids with greater acyl chain lengths are smaller and
more stable than those with shorter acyl chain lengths. Moreover, an increase in the chain
length also increases the resistance of the shell to diffusion [74], [76]. Previous studies
reported a monotonic increase in the viscosity and yield stress of lipids with increasing
chain lengths [78]. The experiments mentioned in this section were performed to
characterize the viscous behavior of OMBs and to set up a protocol to investigate the
viscous and viscoelastic behavior of OMBs using a rotating rheometer with a 1º cone
geometry.

12.1 Experimental design
The primary objective of this study was to develop an understanding of the
rheological profile of OMBs by characterizing their viscous and viscoelastic (VE)
behavior. Further, we investigated the impact of dilution and temperature on the above
behaviors. The samples were used with and without dilution. The samples were diluted to
have a final volume fraction (VF) of 0.7, 0.5, and 0.3. To assess the repeatability, three
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fresh samples were each tested thrice at 23 ºC and 37 ºC. For these experiments, the
headspace of the OMB vial was not primed with O2.

12.2 Materials and Methods
The DSPC lipid OMBs were obtained from the Borden research lab at CUBoulder. The OMBs were stored at 4 ºC prior to use. Rheometry was performed using a
rotating rheometer (AR1500 ex, TA instruments, DE) with a 1 º cone geometry (figure
15.1). As mentioned in the background and literature section, the rheometer calculates the
viscosity by applying a constant angular velocity on the sample and calculating the torque
required to maintain that velocity. The viscosity is calculated from the torque and the
instrument constants and is plotted as a function of the applied shear rate. For the VE
behavior, the storage (G’) and loss moduli (G”) are calculated by applying a sinusoidal
strain or shear stress to the sample, followed by obtaining the peak amplitudes of the
resulting shear stress or strain rate. The peak amplitude of the response corresponds to the
G’ or G” depending on whether the response is in-phase (G’) or out-of-phase (G”).
The OMB vial was gently swirled by holding its neck to enable proper mixing of
the contents. Next, an 18 Ga 5/8” needle was used to withdraw 1 mL of OMBs. In the
development phase, the OMB vial headspace was not primed with O2. The OMBs were
added to a Peltier plate (maintained at room or body temperature). The geometry was
then lowered to make contact with the sample, and the experiment was run. If an excess
sample squeezed out of the plate-geometry gap, it was trimmed off. Prior to adding the
sample, the zero-gap of the rheometer was set to 60 mm. Between the samples, a one-
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minute soak time was allowed. To assess reproducibility and trial-to-trial variation, each
sample was measured thrice. The samples were diluted by adding oxygenated phosphatebuffered saline (oxy-PBS) to perform a dilution-dependent viscosity test. The geometry
was detached, cleaned, and re-attached upon completing each sample test, and the
rheometer was re-calibrated. It should be noted here that the term ‘viscosity’ is used for
Newtonian fluids while ‘apparent viscosity’ is used for non-Newtonian fluids. However,
for simplicity, the term ‘viscosity’ has been used throughout the dissertation.

Figure 12.1: Rotating rheometer.
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12.3 Results
12.3.1 Viscosity of undiluted OMBs at 37 ºC
A shear rate range of 0.01 – 10000 s-1 was chosen for the development phase to
characterize the viscous behavior. Black et al. noted that meaningful viscosity data for
OMBs could be obtained within lower shear rate ranges [92]. All subsequent experiments
were performed in a narrower range of 0-200 s-1. At 37 ºC, the mean viscosity of the
OMBs decreased with increasing shear rates, showing a shear-thinning (pseudoplastic
trend) (figure 15.2). The mean viscosity was calculated from the values obtained by
testing the sample thrice. The error bars at lower shear rates were wider. However, the
difference was not of an order of magnitude. The error bars were narrower at lower shear
rates, similar to the results reported by Black et al. [92].

Figure 12.2: Viscosity vs shear rate for DSPC OMBs for 0.01-10000 s-1.

121

After lowering the maximum strain rate, the test was repeated on three fresh samples of
OMBs (figure 15.3). All the samples showed an initial increase in viscosity (between a
shear rate of 0.1 – 1.0 s-1) that decreased with the shear rate. However, the samples did
not show good reproducibility since there were differences in the order of magnitude
between the three samples. This disagreement may have resulted from unequal sample
mixing prior to testing viscosity. Overall, the OMBs showed a shear-thinning trend in the
viscosity, especially at shear rates beyond 1.0 s-1, similar to the results reported by Black
et al. [92].

Figure 12.3: Viscosity vs. shear rate for n = 3 samples of DSPC OMBs obtained thrice per sample.

12.3.2 Effect of dilution on the viscosity of OMBs at 37 ºC
OMBs can be synthesized at VFs as high as 0.7-0.8. The VF can be reduced by
diluting the OMBs. For this study, the undiluted OMBs having a VF of 0.82 were diluted
to 0.2, 0.4, 0.5, and 0.7 VF. Like the previous results, at all the VFs, the OMBs showed a

122

decreasing viscosity trend (figure 15.4). At shear rates greater than 10 s-1, the viscosity
showed a greater VF dependence. The viscosity values were greater for greater VFs at a
specific shear rate. The viscosity at 0.82 VF dropped below the curve for 0.7 VF,
between 1-10 s-1, followed by a sustained increase at greater shear rates. These results
showed that diluting the OMBs decreased their viscosity for a fixed shear rate (greater
than 10 s-1).

Figure 12.4: Effect of dilution on the viscosity of DSPC OMBs..

12.3.3 Effect of temperature on the viscosity of OMBs
A temperature ramp study was performed to investigate the temperature
dependence of OMB viscosity. The viscosity of OMBs was determined in a temperature
range of 0-45 ºC for the undiluted sample (0.82 VF). The viscosity continuously
decreased with temperature (figure 15.5). This behavior is expected since the viscosity of
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liquids decreases due to the increased movement of molecules resulting from greater
thermal energy.

Figure 12.5: Change of viscosity with increasing temperature (temperature ramp study) for DSPC OMBs.

12.3.4 Viscoelastic behavior of OMBs— storage (G’), loss modulus (G”)
The VE behavior of the sample provides information on the amount of structure
present in a sample (G’) and its ability to dissipate energy (G”). The G’ and G” are
dynamic properties of a sample that provide a range of angular frequencies within which
a sample behaves primarily like an elastic solid or like a viscous fluid. Prior to
performing the oscillation experiment or frequency sweep to determine the G’ and G”,
the linear viscoelastic region for the sample was determined by performing a strain
sweep. In that test, the sample was subjected to a constant angular frequency to determine
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the critical strain%. Beyond the critical value, the sample response (G) is not linear to the
applied strain and therefore is no longer a function of stress or strain only (involves
molecular arrangements). Based on the linear region, a strain % of 0.5% was selected for
all the subsequent oscillation sweep experiments to determine G’ and G”.
For the oscillation experiments (or frequency sweep), the angular frequency was
set at 0.1-100 rad/s for undiluted OMBs (0.82 VF). Throughout the angular frequency
range, the G’ was greater than G”. The G’ increased rapidly between an angular
frequency of 0.1-0.4 rad/s and slowly after that, reaching a mean G’ of 640.5 Pa at 100
rad/s (figure 15.6). On the other hand, the G” first increased between 0.1-0.3 rad/s
followed by a decrease. Between 25-100 rad/s, the G” remained constant at a mean value
of 38 Pa.

Figure 12.6: Storage and loss modulus as a function of angular frequency for DSPC OMBs. An oscillating
input of shear stress was applied to the sample and the resulting shear strain was recorded to provide
storage and loss moduli.
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The phase shift (delta or δ) represents the amount of elasticity present in the
sample. If the material is perfectly VE (equally viscous and elastic), the phase shift is 45º
and tan δ = 1. This behavior is frequency-dependent, and every material has a
characteristic frequency at which this behavior may be seen. In the study discussed here,
the phase and consequently the loss factor (tan δ) continuously decreased with the
increase in the angular frequency. The maximum value was tan δ = 0.6 and δ = 30.4º
(figure 15.7). These results show that the phase angle and the loss factor for the OMBs
remained below 45 º and 1, respectively, indicating that the elastic behavior of OMBs
dominates at higher frequencies. Moreover, the G’ and G” data point towards an
increasing tendency of the sample to store energy at greater frequencies. This behavior
indicates the presence of a structure or of physical entanglements within the that results in
a stiffness imparted to the sample by lipid molecules.

Figure 12.7: Phase and loss factor as functions of the angular frequency for DSPC OMBs.
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12.4 Discussion
The developmental study reported the initial rheometry studies on DSPC OMBs.
Black et al. reported that DSPC OMBs showed a VF-dependent shear-thinning behavior
[92]. Further, they reported that the differences between the viscosity curves of different
VFs were narrow at greater frequencies. The results reported in this study are similar. The
OMBs showed a shear-thinning trend as a function of shear rate. We determined the
viscous behavior for 0.2, 0.4, 0.5, 0.7, and 0.8 VFs (undiluted) of OMBs samples. At all
the dilutions, the viscosity continuously decreased as a function of shear rate except in
the lower shear rates (below 10 s-1), where it increased briefly. Similar results were
reported by Black et al. wherein the viscosity briefly increased at lower shear rates. This
behavior could be partly due to yield stress in the sample. Due to yield stress, the
entangled chains disentangle when a specific shear rate is applied. The sample offers
resistance when the shear rate is applied, due to which the viscosity increases briefly.
Beyond the yield stress, the material starts flowing. Also, the OMB viscosity decreased
with increasing temperature.
The VE nature of the material was shown in the results from G’ and G”. The G’
was continuously greater than G,” indicating the dominant elastic behavior of the OMBs
at greater angular frequency. A greater angular frequency corresponds to a small
observation time and vice-versa. The observation time and relaxation time (characteristic
of a sample) determine a VE sample's elastic or viscous behavior. If the relaxation time is
greater than the observation time, the behavior is primarily viscous. However, the sample
behavior is predominantly elastic if the relaxation time is smaller than the observation
time.
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In this initial study, we did not determine the difference in the size distribution
that may have occurred due to rheometry measurement. Minimizing the size distribution
difference is necessary to ensure that rheometry does not alter the sample concentration.
Additionally, the headspace of the OMB vial was not primed. The above aspects were
considered in the next set of experiments, and the OMB vial headspace was primed prior
to withdrawing the OMB sample. The subsequent experiments determined size
distribution using optical microscopy and a size analyzer.

12.5 Conclusion
The DSPC OMBs showed a shear-thinning trend that was VF- and temperaturedependent. The VE behavior of the OMBs was predominantly elastic at greater angular
frequencies since the G’ was greater than G”.

128

CHAPTER 13 DETERMINATION OF THE SIZE DISTRIBUTION OF OMBs
USING LIGHT MISCROSCOPY-BASED IMAGE PROCESSING AND
MALVERN MULTISIZER®.
An accurate and precise method for determining the size distribution of micro and
nano-sized particles is essential for drug delivery and disease diagnosis applications. The
sizing of therapeutic agents is crucial since it determines the route of administration and
is essential for the delivery of the therapeutic payload. Moreover, the size distribution of
microbubbles (MBs) plays a crucial role in their ultrasound properties. Traditionally, MB
size was determined using a manual hemacytometer or a light microscope coupled with
image processing [93]. Recent improvements have enabled automated size distributions
via Coulter counter, multisizer, or Accusizer. The Coulter counter works on the principle
of electro impedance spectroscopy while the Multisizer and Accusizer work on the
principle of low-angle laser light scattering combined with backscattering [94]. Sennoga
et al. compared the mean MB diameter and number concentrations using electro
impedance spectroscopy, optical microscopy, and laser diffraction [93]. They reported
that electro impedance spectroscopy and optical microscopy can be highly reproducible
when conducted by trained observers, while the laser diffraction method could not [94].
Sennoga et al. also developed a plugin- BubblesizerJ for ImageJ (NIH), that uses image
segmentation with particle size determination and spheroid distance transform to obtain
the size distribution of MBs [95]. The proposed algorithm detects the diameter of each
MB by treating them independently. Sennoga et al. used the BubblesizerJ to compare the
size distributions of commercially available SonoVue MBs with their available diameter
values. They did not find any significant difference between the sizes.
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In this study, we used ImageJ analysis and optical microscopy to analyze OMB images to
obtain the size distribution before and after rheometry. However, in the latter stages of
the project, we collaborated with the Ciftci lab at the food innovation campus at UNL to
use the Mastersizer to perform the size distribution analysis.

13.1 Dilution of OMBs and sample preparation
The OMBs are a suspension of lipid MBs in water/saline. Due to the texture of the
OMBs, it is difficult for light from an optical microscope to penetrate the sample.
Therefore, a 1-2 µL sample of OMBs was diluted with an equal volume of PBS. In one
approach, the diluted sample was added onto a glass slide and spread uniformly. Care
was taken not to introduce any air bubbles due to the difficulty differentiating OMBs
from the air bubbles under a microscope. The glass slide was then viewed under an
optical microscope at 400X magnification (figure 16.1). In the other approach, the sample
was sandwiched between two glass slides to prevent the flow of OMBs upon spreading.

a

b

Figure 13.1: Images obtained from optical microscopy for OMBs (a) before and (b) after rheometry.
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13.2 Image processing to obtain the size distribution of OMBs
The technique reported by Sennoga et al. was followed to determine the diameter
of the OMBs [95]. The OMBs were first photographed, then imported into the ImageJ
software. Next, the pixel length of a 400X magnified image of a 1mm scale was
calculated. This pixel length (for 1 mm) was used to set up a new scale for the OMB
image. The image was then subjected to automatic thresholding to highlight the bubble
outlines. If necessary, bandpass filtering was applied. The OMB size distribution was
determined using Feret’s approximation (figure 16.2). A circularity of 0.95-1.00 was
used. The OMB diameter was analyzed using GraphPad Prism software.
Upon analyzing the data obtained, several issues were encountered. First, it was
not always possible to clearly outline all the bubbles in the image. Secondly, large air
bubbles in the sample were evident to the naked eye but could not be distinguished from
the OMBs under the microscope. These air bubbles possibly skewed the distribution
giving an inappropriate size distribution. Thirdly, the sample was difficult to image when
not sandwiched. Moreover, it was difficult to focus on a single layer of OMBs, and as a
result, there was noise from the layers beneath. These OMBs were not clearly outlined
upon thresholding, affecting the size distribution.
Additionally, the software recognized a single pixel as an OMB of a very small
diameter, affecting the size distribution. Moreover, as seen in figure 16.2, the OMB size
distribution was not continuous. As a result, the size distribution from image processing
was later abandoned in favor of an automated size analyzer. The size distribution
obtained from ImageJ was then compared with the original size distribution provided by
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CU-Boulder (figure 16.3). The comparison revealed several shortcomings in using the
former to obtain the OMB size distribution.

Figure 13.2: Particle size distribution using Feret’s diameter approximation from ImageJ analysis.
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Figure 13.3: Particle size distribution obtained using Accusizer at CU-Boulder.

13.3 Size distribution analysis using light-scattering based Malvern Mastersizer®
Several issues from the presence of air bubbles in the sample, difficulties in
clearly outlining the OMBs using image processing, and issues from pixelation led to
discontinuation of light microscopy and image processing to determine the size
distribution. Moreover, light microscopy leads to noise from different focal planes.
Therefore, we collaborated with the Ciftci lab at the food innovation campus at UNL to
use the Malvern Mastersizer®. The Mastersizer® uses a size distribution technique based
on light-scattering of individual particles.
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We performed the analysis on DPPC OMBs. The OMB headspace was primed
with O2 prior to withdrawing a sample. The size analysis was performed to determine the
differences in the size distribution resulting from rheometry (figure 14.3). The mean
OMB diameter before rheometry was 16.0 µm and after rheometry was 20.2 µm as
shown by the peaks of the curves showing some coalescence after rheometry. However, it
should be noted that the size distribution analysis was not performed immediately after
the OMB synthesis and involved at least one week of idle time before the analysis (due to
transportation). Approximately 90% of the OMBs were below a diameter of 24.3 and
31.0 µm, before and after rheometry, respectively. The mean sizes did not have a
statistically significant difference.

Figure 13.4: Particle size distribution obtained using Mastersizer.

13.4 Conclusions
In this preliminary study, an attempt was made to study the impact of rheometry
on the size distribution of OMBs. The image processing tool (ImageJ) was combined
with optical microscopy to obtain the size distributions before and after rheometry.
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However, this technique did not provide accurate size distributions due to pixelation and
the presence of air bubbles. The Malvern Mastersizer® provided better results. There was
a 26% increase in the mean diameter of the OMBs after rheometry. However, the mean
diameters did not have a statistically significant difference, and the difference cannot be
solely attributed to rheometry since the OMBs are exposed to the atmosphere during
sample preparation for rheometry and also during the size distribution analysis. Overall,
the DPPC OMBs are known to be the least stable compared to DSPC and DBPC and
therefore it may be predicted that the DSPC and DBPC OMBs will not have a significant
change in size distribution resulting from rheometric testing. These results can help
predict the degradation that may be induced from rheometric measurements.
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CHAPTER 14 INVESTIGATING THE VISCOUS AND VISCOELASTIC
BEHAVIOR OF DIFFERENT LIPID SHELL OMBs WITH VARIOUS VOLUME
FRACTIONS
The results from the developmental experiments showed a shear-thinning trend in
the viscous behavior of the DSPC OMBs. Moreover, the viscosity decreased with the
increase in temperature. The frequency sweep tests provided the G’ and G”. The G’
remained greater than the G”, pointing towards a predominantly elastic behavior with
increasing angular frequency. However, as noted in the previous section, the headspace
of the OMB vial was not primed with O2 for the rheometry studies and for the size
analysis using light microscopy, which may have affected the OMB size. When the OMB
vial is primed with 100% O2, there is minimal or no concentration gradient for the O2 to
diffuse out of the core.
For all the subsequent rheometry studies described in this section, the OMB vial
was always primed prior to OMB withdrawal. Using ImageJ for size distribution analysis
was abandoned in favor of automated size distribution using a Malvern Mastersizer®. In
this study, results from the viscous and VE behavior of DSPC-, DBPC-, and DPPC-shell
OMBs are reported for different VFs at 23 °C and 37 °C.

14.1 Experimental design
The experiments were performed at 23 ºC and 37 ºC to study a temperaturedependent effect on the relevant properties. Three fresh samples were used for each test
(viscosity and frequency sweep tests), and the data were averaged. The tests were
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performed at four dilutions- 0.3 VF, 0.5 VF, 0.7 VF, and the undiluted VF. The undiluted
VFs for DSPC, DBPC, and DPPC OMBs were 0.786, 0.739, and 0.789, respectively.

14.2 Materials and methods
The OMBs were refrigerated at 4 ºC when not in use. To prepare the different
dilutions, the following method was used:
F1V1 = F2V2
where,
F1 and F2 are the initial and final VFs, respectively. V1 is the volume of OMBs of F1 VF
(undiluted), while V2 is the final volume of the desired VF (F2). A sample calculation is
shown below:
For 0.3 VF,
F1 = 0.789,
F2 = 0.3,
V2 = 24 mL (volume required to perform all the tests).
F1V1 = F2V2
V1 = F2V2/ F1 = 0.3*24/ 0.789 = 9.1 mL.
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Therefore,
9.1 mL of undiluted OMBs were mixed with 14.9 mL of oxy-PBS to obtain 24 mL of 0.3
VF OMBs.
Other dilutions were prepared similarly. To withdraw the required volume of
OMBs, the OMB headspace was primed with 100% O2 in the same manner as described
in section 10.3. Prior to withdrawing OMBs, the required volume of oxy-PBS was taken
in a syringe. Next, the OMBs were withdrawn in the syringe and gently mixed to obtain a
homogenous mixture. For this phase and all other phases, an Anton Paar (Ashland, VA)
rotating rheometer at the Ciftci lab (UNL) was used (instead of the one used previously)
due to its proximity to the Mastersizer® device. For each test, 1 mL of the sample was
added onto the Peltier plate of the device. The geometry was then lowered to make
contact with the sample. The excess sample was trimmed. All the tests were performed
between the shear rates of 1-200 s-1.

14.3 Results
14.3.1 Apparent viscosity vs. shear rate
14.3.1a DSPC OMBs
The viscosity decreased with the shear rate for all the VFs at 23 ºC and 37 ºC. For
the DSPC OMBs, the undiluted VF was 0.786. The viscosity regime showed a VFdependent behavior wherein OMBs with 0.3 VF showed the lowest viscosity (at a given
shear rate), followed by 0.5 VF, 0.7 VF, and the undiluted sample (figure 14.1). Under
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both, the temperatures, the viscosity for 0.7 VF and the undiluted sample showed a
plateau between 24 s-1 and 60 s-1. However, this plateau region was not seen at lower
VFs. At 23 ºC, the differences in the viscosity at greater shear rates (60-200 s-1) were less
compared to lower shear rates. Moreover, the viscosities at a fixed shear rate for a
specific dilution were lower at 37 ºC (figure 14.2). For certain VFs, the viscosity did not
show a dilution-dependent change at low shear rates (< 10 s-1). However, at shear rates
greater than 10 s-1, the viscosity was always dilution-dependent, with greater dilutions
showing lower viscosities for a fixed shear rate. Plots showing a comparison of
viscosities at 23 °C and 37 °C are given in appendix G.1.

Figure 14.1: Viscosity measured for different VFs of DSPC OMBs at 23 ºC.
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Figure 14.2: Viscosity measured for different VFs of DSPC OMBs at 37 ºC.

14.3.1b DBPC OMBs
The viscosity of the DBPC OMBs decreased with increasing shear rates. The
decrease in viscosities was seen for both 23 °C and 37 °C. The shear-thinning behavior
dependence on VFs was more prominent at greater shear rates. Interestingly, similar to
the DSPC OMBs, the DBPC OMBs showed a plateau region for 0.7 VF and the undiluted
sample. This behavior was seen in the shear rate range of 12 s-1 and 49 s-1. This plateau
region was not seen at greater shear rates. The difference between the different VF curves
was lower for lower shear rates and widened at greater shear rates at 23 °C (figure 14.3).
However, the difference between the curves at greater shear rates was comparatively
lower at 37 °C (figure 14.4). For a fixed shear rate and VF, the viscosity was lower at 37
°C than at 23 °C showing a temperature dependence. Plots showing a comparison of
viscosities at 23 °C and 37 °C are given in appendix G.2.
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Figure 14.3: Viscosity measured for different VFs of DBPC OMBs at 23 ºC.

Figure 14.4: Viscosity measured for different VFs of DBPC OMBs at 37 ºC.
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14.3.1c DPPC OMBs
The DPPC lipid OMBs also showed a shear-thinning behavior as the viscosity
decreased with increasing shear rates. At 23 °C, the viscosity for 0.3 VF increased
between 8-24 s-1 followed by a continuous decrease at shear rates beyond 24 s-1 (figure
14.5). This behavior was also seen at 0.5 and 0.7 VFs, wherein the viscosity increased at
lower shear rates, followed by a continuous decrease. The plateau region at 0.7 VF was
also seen for DSPC and DBPC OMBs, at the same volume fraction. Similar behavior was
observed at 37 °C, wherein the viscosity for 0.3, 0.5, and 0.7 VFs increased for 8-24 s-1
followed by a decrease (figure 14.6). The viscosity trend was VF-dependent. Moreover,
the viscosities at a given shear rate were lower at 37 °C than at 23 °C. These results show
that the DPPC lipid OMBs possess a shear-thinning behavior that is VF and temperaturedependent. Plots showing a comparison of viscosities at 23 °C and 37 °C are given in
appendix G.3.

Figure 14.5: Viscosity measured for different VFs of DPPC OMBs at 23 ºC.
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Figure 14.6: Viscosity measured for different VFs of DPPC OMBs at 37 ºC.

14.3.2 Comparison of the viscous behavior of DSPC, DBPC, and DPPC OMBs
As mentioned in chapter 12, Kim et al. reported a chain-length dependent increase
in the viscosity of lipids [78]. Our study investigated the rheological behavior of lipids
with 16, 18, and 22 carbon chains (DPPC, DSPC, and DBPC). For all the VFs, the
viscosity at a given shear rate was the highest for the DBPC OMBs, followed by DSPC
and DPPC at 23 °C and 37 °C (figures 14.7 and 14.8). The differences in the viscosity
narrowed with the increase in the shear rate for all the OMBs. These results agree with
those reported by Kim et al. for increasing the acyl chain length [78]. The increase in
lipid chain length makes the lipid shell more rigid and increases the resistance to flow. As
a result, the viscosity increases, as seen from the above results. The plots for undiluted
samples have been re-plotted together for a visual comparison. For the sake of simplicity,
the plots for other VFs are shown in appendix E.1-3.
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Figure 14.7: Comparison of the DSPC, DBPC, and DPPC OMBs at undiluted VFs of 0.786, 0.739, and 0.789 at 23 ºC.

Figure 14.8: Comparison of the DSPC, DBPC, and DPPC OMBs at undiluted VFs of 0.786, 0.739, and 0.789 at 37 ºC.
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14.3.3 Storage and loss modulus (G’, G”)
The figures in this section have been reported without the error bars to prevent the
figures from being convoluted. The figures with error bars are shown in appendix F.

14.3.3a DSPC OMBs
The G’ and G” were determined by using a frequency sweep test wherein an
oscillation frequency was applied to the sample in the range of 1-200 rad/s. When the
frequency was in the range of 1-4 rad/s, the G’ and G” fluctuated as seen from figures
14.9 and 14.10. The figure shows that G” was initially greater than G’ at all the dilutions
and dropped below it at frequencies greater than 4 rad/s. This result shows that the OMBs
had a predominantly viscous behavior at frequencies below 4 rad/s and a predominantly
elastic behavior at greater frequencies. Moreover, both G’ and G” increased with the
increase in frequency. The continuous increase in G’ with the frequency points to the
presence of structure and entanglements in the sample, enabling it to store energy and
display an elastic behavior. The G” also increased, showing the ability of the sample to
dissipate energy. However, since the G’ was always greater than G”, the OMBs show
predominantly elastic behavior in the frequency range of 4-200 rad/s. At both the
temperatures, the OMBs at different VFs showed an equal G’ and G” (perfectly
viscoelastic) in a frequency of 1.73-2.08 rad/s. However, this behavior was not sustained
at other frequencies. The G’ and G” values were greater for greater VFs and therefore
showed a concentration or VF dependence at both the temperatures. The G’ and G” did
not show a temperature-dependent behavior as the values were similar for a fixed
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frequency at each temperature. The differences in the G’ or G” was not very evident at
higher angular frequencies. The curves for 23 °C and 37 °C were not plotted together for
simplicity. Individual plots are reported in appendix F.1.

Figure 14.9: Storage and loss moduli measured for different VFs of DSPC OMBs at 23 ºC.

Figure 14.10: Storage and loss moduli measured for different VFs of DSPC OMBs at 37 ºC.
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14.3.3b DBPC OMBs
The G’ and G” for DBPC OMBs showed a behavior similar to the DSPC OMBs.
For lower frequencies of 1-4 rad/s, the G’ and G” fluctuated, with the G” being initially
greater than the G’ (figures 14.11 and 14.12). Beyond 4 rad/s, the G’ was always greater
than G,” and this difference was sustained at greater frequencies. The G’ values
continuously increased while the G” showed a slight decrease between 4-22 rad/s,
followed by an increase. The G’ and G” values were equal within frequencies of 1.40 to
2.08 rad/s. The G’ and G” values showed a VF dependence— greater VFs showed a
greater G’ and G” value at a fixed angular frequency. However, an exception was noted
for 0.7 VF wherein the OMBs with undiluted VF showed a G’ and G” value that was
lower than the 0.7 VF. This discrepancy may be due to inadequate mixing and
experimental disturbance. Results for 23 ºC and 37 ºC are compared in appendix F.2.

Figure 14.11: Storage and loss moduli measured for different VFs of DBPC OMBs at 23 ºC.
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Figure 14.12: Storage and loss moduli measured for different VFs of DBPC OMBs at 37 ºC.

14.3.3c DPPC OMBs
The G” for the DPPC OMBs was greater than G’ for lower shear rates, similar to
DSPC and DBPC OMBs. At greater shear rates, the difference between G’ and G”
widened with G’ being greater than G”. Within a range of 1.70-3.00 rad/s, the G’ and G”
values were found to be equal for the different VFs. Since the G’ > G” at greater
frequencies, the OMBs possessed a dominantly elastic behavior when the experimental
(or observation) is small or rapid. Moreover, the G’ and G” values were VF-dependent
since increasing the VF led to a greater G’ or G” at a particular frequency. It was also
noted that the difference between the G’ or G” for the different VFs narrowed at greater
frequencies. The G’ or G” curves did not show a temperature dependence since similar
values were observed across all the VFs for 23 °C and 37 °C (figures 14.13 and 14.14).
Results for 23 ºC and 37 ºC, are compared in appendix F.3.
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Figure 14.13: Storage and loss moduli measured for different VFs of DPPC OMBs at 23 ºC.

Figure 14.14: Storage and loss moduli measured for different VFs of DPPC OMBs at 37 ºC.
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14.3.4 Comparison of the viscoelastic behavior of DSPC, DBPC, and DPPC OMB
The G’ and G” showed a trend wherein the values for the DBPC OMBs were
greater, followed by DSPC, and DPPC (DBPC > DSPC > DPPC) at lower angular
frequencies (less than 15 rad/s). At larger frequencies (corresponding to shorter
timescales), the difference in the G’ and G” values was narrow. The chain dependent
change in the G’ and G” was only seen at lower frequencies. The loss modulus also
followed a similar trend. The figures for different VF comparisons of G’ and G” for the
different OMBs are shown in appendix G.

14.5 Discussion
The viscous and VE behavior of OMBs was characterized using a rotating
rheometer with a cone geometry. All the studies were performed at 23 °C and 37 °C with
four different VFs. At all the VFs, the OMBs showed a shear-thinning behavior via a
viscosity decrease with the increasing shear rate. This behavior was seen at both
temperatures, similar to the developmental experiment results. Moreover, the
repeatability was better after changing the study protocol by priming the headspace of the
OMB vial. As noted in the results section, the viscosity of OMBs increased with the
increase in the VF for a fixed shear rate. This behavior shows a VF-dependent flow
behavior of the OMBs. Similar results were reported by Black et al. wherein OMBs with
95% VF showed a greater viscosity at lower shear rates compared to lower VFs [92].
However, this difference narrowed at greater shear rates. In the present study, we noted a
similar behavior wherein the difference in the viscosities narrowed at higher shear rates.
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For undiluted and 0.7 VF, the viscosity showed a plateau between 24-60 s-1, but this
behavior was not seen at greater shear rates or lower VFs. The viscosity was also lipidchain dependent wherein the DBPC OMBs showed the highest viscosity at a particular
shear rate.
The frequency sweep tests showed that the G’ was lower than G” at low angular
frequencies (less than 4 rad/s). However, G’ was greater than G” at all frequencies above
4 rad/s. The result shows that the OMBs behave predominantly like an elastic solid at
greater frequencies. The G’ is associated with the amount of structure and chain
entanglement present in a material. Due to the structure, the energy is stored when a load
is applied, giving a large G’. However, if the G” is greater, it indicates a tendency of the
material to dissipate energy via heat and is characteristic of a fluid. Therefore, a higher
G’ shows a dominantly elastic behavior of a VE material. Similar to the viscosity results,
the G’ and G” values were greater for greater VFs for a given frequency, showing a VFdependent behavior.
Moreover, the differences between the G’ and G” curves were narrow at greater
frequencies. The G’ and G” values are useful in calculating the Deborah number (De)
that distinguishes how a particular material behaves over a certain timeframe. It is a
function of the characteristic material time. When the G’ > G”, the resultant De number is
less than 1. Consequently, the behavior of the material is predominantly elastic. The
opposite is true when the G’ < G”, resulting in a De number greater than 1, causing a
predominantly fluid behavior of the material. On the other hand, De =1 when G’ = G”
and the material has equally elastic and viscous behavior.
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Similar to the DSPC lipid OMBs, the viscosity of the DBPC lipid OMBs
decreased with temperature for a fixed VF and shear rate. This behavior shows that the
OMBs show a greater tendency to flow at higher temperatures due to their lower
viscosity. The frequency sweep results of this study were similar to the previous study.
The G’ and G” values increased with increasing angular frequency. However, a plateau
was seen between 4-22 rad/s. The G’ remained greater than G” at higher shear rates (> 4
rad/s), showing the tendency of the OMBs to show a predominantly elastic behavior. The
OMBs seem to have a dominant fluid behavior at very low frequencies that changes to a
dominantly elastic behavior at greater frequencies. The G’ and G” behavior showed a VF
dependence as OMBs with a greater VF showed higher G and G” values. The VE
behavior did not show a temperature-dependent behavior. However, an anomalous
behavior was observed for the undiluted (0.739) VF that is likely an experimental-related
error since the previous study and the developmental experiments showed a VF
dependence of G’ and G”.
The results for DPPC lipid OMBs followed a trend similar to those reported for
the DSPC and DBPC lipid OMBs. The viscous behavior was shear-thinning and showed
a VF and temperature dependence. These results are important to develop an
understanding of the behavior of OMBs when they are stored or administered at a
specific temperature. The viscosity of the OMBs plays a crucial role in their circulation in
body cavities or the blood vessels when they are administered intravenously. The results
from the frequency sweep help predict the OMB behavior when dynamic stress or strain
is applied to them. They also help in predicting the response of the material over a certain
timescale and provides an insight into the relaxation time of the material. The OMBs
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either show an overall elastic or viscous behavior in response to the applied stress/strain.
In this study, the G” was greater than G’ only in a narrow range at small frequencies. At
all other frequencies, the G’ value was always greater than G”. The VE behavior was VFdependent but did not show a temperature dependence.

14.6 Conclusion
The DSPC, DBPC, and DPPC OMBs showed a non-Newtonian behavior that was
shear-thinning. This behavior was VF- and temperature-dependent. The VE behavior of
the OMBs was also VF-dependent and revealed a predominantly elastic behavior at
greater angular frequencies.
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CHAPTER 15 FITTING NON-NEWTONIAN FLUID MODELS TO THE SHEAR
STRESS-SHEAR RATE BEHAVIOR
The rheology of suspensions has been explored extensively due to their wide
range of applications in industry and medicine. A concentrated suspension typically
shows a viscosity-shear rate curve consisting of a Newtonian plateau region, a shearthinning region, and a second Newtonian plateau. The first plateau is found in regions of
low shear rate and can be described by apparent yield stress. The non-Newtonian
behavior of fluids can be explained using models like the Power-law model, Casson
model (used to describe blood flow in vessels), Herschell-Bulkley model, Carreau model,
and Carreau-Yasuda model, among others [96]. Some of these may be suitable for fluids
that possess yield stress. For instance, the blood consists of plasma, RBC, and proteins.
Plasma is a Newtonian fluid with viscosity ranging from 1.16-1.35 mPa.s. The viscosity
of plasma is due to the presence of several proteins [97]. However, it is interesting to note
that despite the Newtonian behavior of plasma, the blood has a non-Newtonian behavior
due to the presence of RBCs. The blood also possesses yield stress, which depends on the
value of the hematocrit. However, below a hematocrit of 0.04, blood does not exhibit any
yield stress. When the applied shear stress exceeds the yield stress value, blood shows a
shear-thinning behavior. When the shear rate exceeds 100 s-1, blood behaves like a
Newtonian fluid. The simplest constitutive equation proposed to model blood flow is the
Casson equation, which is:

τ1/2 = τo1/2 + K1/2 ɣ1/2
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where,
𝜏𝜏 – shear stress,

𝜏𝜏o – yield stress,

K – consistency index,
ɣ - shear rate.
The blood viscosity is due to the presence of fibrinogen in the plasma that binds
to the RBCs and causes them to aggregate. At greater shear rates, these aggregates break
and lower the viscosity. Sirsi et al. predicted that the size similarity of OMBs and RBC
may lead to similarity in their viscous behavior [71].
This chapter compares the results from viscosity and frequency sweep tests on
DSPC, DBPC, and DPPC lipid OMBs described in the previous chapters and reports the
results from fitting shear-thinning fluid models to the DSPC, DBPC, and DPPC lipid
OMBs. For this purpose, the Casson-model (C), Herschell-Bulkley-model (HB), and
Power law-model (P) were fitted to the shear stress-shear rate data by non-linear
regression to evaluate the model fit and to obtain the best-fit parameters for yield stress
and the power-law index. The relevant equations are shown in table 20.1.
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Table 15.1: Equations for fluid models used in the analyses
Model

Equation

1

Casson model

2

Herschell-Bulkley

τ1/2 = τo1/2 + K1/2 ɣ1/2

3

Power-law

τ = τo + K ɣ
τ = K ɣn

Table 15.2: Different parameters used in the model fits
Parameter

Stands for

𝜏𝜏

Shear stress

𝜏𝜏o
K

Consistency index

ɣ

Shear rate

n

Power index

Yield stress

15.1 Methods
To compare the viscosity results for the different OMBs, the data from DSPC,
DBPC, and DPPC OMBs reported in the previous chapters were plotted together to study
the influence of lipid chain length on the OMB viscosity. For the model fitting, a nonlinear regression analysis was performed on the shear stress vs. shear strain data for all
the OMBs at 23 °C and 37 °C. The analyses were performed using GraphPad Prism
software (San Diego, CA). The three model fits were compared using the Akaike
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information criterion (AIC) to obtain the best model to explain the data. The AIC
determines the information value of the model using the maximum likelihood estimate
and the number of parameters (independent variables) in the model.
It uses the following equation:
AIC = 2*K – 2*ln(L)
where K is the number of parameters, ln(L) is the log-likelihood estimate.
The likelihood estimate (L) refers to the likelihood that a model could produce the fitted
data. When comparing model 2 to model 1, if the difference in the AIC values is greater
than -2, the models have a significant difference, and model 2 is considered to have a
better likelihood of explaining the data. However, it should be noted that AIC is sensitive
to the number of parameters. Therefore, a model with fewer parameters will have a
greater AIC.

15.2 Model fit for DSPC lipid OMBs
The DSPC OMBs showed a shear-thinning behavior in a VF-dependent manner.
The viscosity of the OMBs decreased with an increase in the temperature for a fixed
shear rate. In the present study, the C, HB, and P were fitted to the shear stress versus
shear rate data obtained at 23 °C and 37 °C. The C model fit showed the lowest R2 value
for all the VFs. For instance, at 0.3 VF, the R2 value was 0.59, compared to 0.7 for HB
and P. The R2 refers to the coefficient of determination and explains the percentage of
variation that can be explained by the regression line. Therefore, it can be understood
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here that using the C model, 59% of the variation in the shear stress values can be
explained by the shear rate variation. The AIC predicted the P model to be a better model
to explain the data. Although the R2 values reported for the HB model were the same, the
95% confidence intervals for the best-fit parameters were orders of magnitude wide. At
23 °C, the R2 values were greater for higher VFs showing that concentrated samples
showed better model fits (figure 15.1-15.4). The undiluted sample showed an R2 of 0.8,
0.93, and 0.93 for the C, HB, and P models, respectively. The C and HB models also
predicted the presence of yield stress.
The behavior at 37 °C was different (figure 15.5-15.8). Although the R2 values
were greater for HB and P models than the C model, the 0.5 VF sample showed the
highest R2 value among other VFs. The model fit did not depend on the temperature at
which the data was obtained. However, the data for each VF showed greater R2 values at
23 °C compared to 37 °C. For example, at 0.3 VF for the P model, R2 = 0.51 at 37 °C and
R2 = 0.70 at 23 °C. This section shows that the NN (non-Newtonian) models explained
the variation in shear stress better at lower temperatures. Moreover, the AIC predicted
that the P model is better for explaining the OMB behavior.
As explained above, the C and HB models predicted the presence of yield stress
in the sample. However, it should be noted that the P model has fewer parameters than
the C and HB models. The number of parameters in a model strongly impacts the AIC
score. Consequently, models with fewer parameters have greater AIC scores. The best-fit
parameters for DSPC OMBs are shown listed in appendix H.
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Figure 15.1: Regression analysis for shear stress data for DSPC OMBs at 0.3 VF for 23
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Figure 15.2: Regression analysis for shear stress data for DSPC OMBs at 0.5 VF for 23 ºC.
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Figure 15.3: Regression analysis for shear stress data for DSPC OMBs at 0.7 VF for 23 ºC.

R2

C

HB

P

0.52

0.62

0.62

Figure 15.4: Regression analysis for shear stress data for DSPC OMBs undiluted (0.789 VF) for 23 ºC.
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Figure 15.5: Regression analysis for shear stress data for DSPC OMBs at 0.3 VF for 37 ºC.
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Figure 15.6: Regression analysis for shear stress data for DSPC OMBs at 0.5 VF for 37 ºC.
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Figure 15.7: Regression analysis for shear stress data for DSPC OMBs at 0.7 VF for 37 ºC.

R2

C

HB

P

0.63

0.72

0.79

Figure 15.8: Regression analysis for shear stress data for DSPC OMBs undiluted (0.786 VF) for 37 ºC.
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15.3 Model fit for DBPC lipid OMBs
The DBPC lipid OMBs also showed a shear-thinning behavior similar to the
DSPC lipid OMBs and were VF and temperature-dependent. Similar to the previous
result, the variation in the shear stress was better explained by the HB and P models,
(evident from the comparatively greater R2 values) compared to the C models for all the
VFs. For the undiluted OMBs, the C, HB, and P models provided R2 values of 0.91, 0.95,
and 0.95, respectively. Based on the AIC, the P model showed a greater likelihood of
explaining the variation in shear stress vs. shear rate data. Moreover, similar to the DSPC
OMBs, the R2 value for the models for different VFs at 23 °C (figure 15.9-15.12) was
either equal to or greater than those at 37 °C (figure 15.13-15.16). The HB model
provided the best-fit parameters with very wide 95% confidence intervals. Generally,
despite high R and R2 values, if a model provides best-fit parameters with wide intervals,
the model is interpreted with caution. Compared to the HB model, the C and P model
provided best-fit estimates of the different parameters with 95% confidence intervals
within the same order of magnitude. The model fit did not seem to be dependent on the
VF. As mentioned earlier, the C and HB model results predict the presence of yield stress
in the OMB sample. The best-fit parameters for DBPC OMBs are shown listed in
appendix I.
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Figure 15.9: Regression analysis for shear stress data for DBPC OMBs at 0.3 VF for 23 ºC.
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Figure 15.10: Regression analysis for shear stress data for DBPC OMBs at 0.5 VF for 23 ºC.
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Figure 15.11: Regression analysis for shear stress data for DBPC OMBs at 0.7 VF for 23 ºC.
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Figure 15.12: Regression analysis for shear stress data for DBPC OMBs undiluted (0.739 VF) for 23 ºC.
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Figure 15.13: Regression analysis for shear stress data for DBPC OMBs at 0.3 VF for 37 ºC.

R2

C

HB

P

0.53

0.67

0.67

Figure 15.14: Regression analysis for shear stress data for DBPC OMBs at 0.5 VF for 37 ºC.
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Figure 15.15: Regression analysis for shear stress data for DBPC OMBs at 0.7 VF for 37 ºC.

R2

C

HB

P

0.69

0.73

0.73

Figure 15.16: Regression analysis for shear stress data for DBPC OMBs undiluted (0.789 VF) for 37 ºC.
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15.4 Model fit for DPPC lipid OMBs
The results from this study were similar to those from the DSPC and DBPC
OMBs. The DPPC lipid OMBs also showed a VF-dependent and temperature-dependent
behavior of the OMB viscosity as a function of shear rates. When non-linear regression
was performed, the highest R2 values were obtained for the HB and P models.
Interestingly, even in the case of DPPC OMBs, the R2 values were greater at 23 °C. For
example, for the undiluted sample, R2 = 0.82 (C), 0.97 (H), 0.97 (P) at 23 °C (figure
15.17-15.20) compared to R2 = 0.75 (C), 0.89 (H), 0.93 (P) at 37 °C (figure 15.21-15.24).
The HB predicted best-fit parameters showed a very wide 95% confidence interval. The
AIC predicted the P model to be a better fit compared to others for the data at both 23 °C
and 37 °C. The best-fit parameters for DPPC OMBs are shown listed in appendix J.

Figure 15.17: Regression analysis for shear stress data for DPPC OMBs at 0.3 VF for 23 ºC.
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Figure 15.18: Regression analysis for shear stress data for DPPC OMBs at 0.5 VF for 23 ºC.
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Figure 15.19: Regression analysis for shear stress data for DPPC OMBs at 0.7 VF for 23 ºC.
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Figure 15.20: Regression analysis for shear stress data for DPPC OMBs undiluted (0.736 VF) for 23 ºC.
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Figure 15.21: Regression analysis for shear stress data for DPPC OMBs at 0.3 VF for 37 ºC.
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Figure 15.22: Regression analysis for shear stress data for DPPC OMBs at 0.5 VF for 37 ºC.
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Figure 15.23: Regression analysis for shear stress data for DPPC OMBs at 0.7 VF for 37 ºC.
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Figure 15.24: Regression analysis for shear stress data for DPPC OMBs undiluted (0.736 VF) for 37 ºC.
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15.5 Discussion
In this study, we fitted the models of NN fluid to the data of shear stress vs. shear
rate. The models with and without yield stress parameters were used to study the
variation in the shear stress as a function of shear rate. Kim et al. reported in their study
that increasing the acyl chain length of lipids increases their viscosity and the yield stress
in a monotonic manner [78]. Therefore, it may be expected that in the current study, the
viscosity and the yield stress follow the pattern of DBPC (22 carbons) > DSPC (18
carbons) > DPPC (16 carbons). Our study found that the viscosity depended on the OMB
shell lipid chain length, OMB VF, and the measurement temperature. The viscosities of
OMBs with a longer lipid chain were greater than those with a smaller one at the same
shear rate and temperature. This result shows that the viscosity changes with the acyl
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chain length of the lipids. Kim et al. reported similar results in their work on
characterizing the properties of phospholipid monolayer shells formed on the gas bubbles
as a function of the shell composition.
The regression analysis from our study showed that at all the VFs, the variation
in the shear stress was better explained by the HB and P models, as evident by the
comparatively greater R2 values. Moreover, the reported R2 values were greater at 23 °C
than at 37 °C. We observed a decrease in the viscosity with temperature for a given shear
rate in the developmental experiments. This result showed that the OMBs have a lower
flow resistance at higher temperatures. As a result, the associated shear stress also lowers
for a fixed shear rate for a greater temperature. This behavior was noted for all the
OMBs. The model-fit results for the C and the HB models predict yield stress values.
Interestingly, the best-fit yield stress values for the DSPC OMBs increased with the
increase in the VF at both 23 °C and 37 °C. The values for the 0.3, 0.5, 0.7, and undiluted
samples were 0.93, 1.7, 2.65, and 3.33 Pa, respectively, at 23 °C. These results are
expected since increasing the concentration, or VF increases the number of OMBs and
thus the lipid molecules. For DBPC and DPPC OMBs, a similar behavior was seen
wherein yield stress increased with the VFs. Moreover, for all the lipids, the yield stress
was lower at 37 °C compared to 23 °C.
This result provides an important insight into the behavior of OMBs since it is
understood that the yield stress lowers at greater temperatures due to the increased
movement of molecules within the sample because of increasing thermal energy. As a
result, the stress required to initiate flow reduces with increasing temperature. The
predicted yield stress was lowest at the respective VFs for the DPPC OMBs. Although
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the DBPC OMBs are expected to possess greater yield stress according to Kim et al.,
some exceptions were seen from our predicted values [78]. Since the parameter values
predicted by the HB model were associated with wide 95% confidence intervals, they
were not included in the analyses. The ‘n’ values predicted by the P and HB models were
in a range of 0.18-0.71. predicting a shear-thinning behavior, that was observed in the
viscosity versus shear rate study. The ‘n’ values predicted by the HB and P models were
within a 10% difference.

15.6 Conclusion
The DSPC, DBPC, and DPPC OMBs showed a shear-thinning behavior. The HB
and P models better explained the variations in shear stress as a function of the shear rate,
however, the best-fit parameters predicted by the HB models were within wide 95%
confidence intervals. The yield stress predicted by the C model was greater for OMBs
with longer lipid chains.
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CHAPTER 16 OVERALL DISCUSSION AND CONCLUSION
Oxygen supplementation via the peritoneal cavity was explored in different
studies reporting animal models of hypoxia. Different artificial oxygen carriers have been
tested in the past. The peritoneal membrane oxygenation (PMO) is a novel method to
augment systemic circulation by administering OMBs to the peritoneal cavity. The
peritoneum then functions as a membrane for the exchange of gases. The pressure
gradient of O2 across the capillary-membrane interface increases the diffusion of O2 to
the capillaries. The diffused O2 then diffuses to the systemic circulation. The objective of
PMO is to provide oxygen supplementation in critical conditions wherein complications
from ECMO and mechanical ventilation exacerbate the injury and are inadequate to
provide oxygenation. Previously, our lab performed extensive work in small and large
animal models by investigating the effect of OMB administration via the peritoneal
cavity under ARDS conditions, as explained in section 8.5. In that work, we showed that
the intraperitoneal administration of DSPC OMBs in rats and rabbits augmented oxygen
levels and led to greater survival.
In the follow-up studies, the effect of DSPC OMB administration was
investigated in awake rats, wherein the OMB treatment improved the survival of rats
compared to saline and no treatment counterparts. In the work described in this
dissertation, the effect of OMBs of different shell types on the survival of rats with
ARDS was investigated. Also, the rheological properties of OMBs were investigated at
different volume fractions and temperatures. Experiments were designed to compare
survival outcomes of rats with ARDS upon the IP administration of DSPC, DBPC, and
DPPC lipid OMBs. Since the chain length impacts the stability, it was worthwhile to
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explore the differences in the survival outcomes to identify the best lipid composition for
the OMBs. Due to the fluid nature of OMB suspensions, viscous and viscoelastic
behavior was investigated. Previous studies reported multiple aspects of viscosity and the
yield stress of phospholipid membranes. However, this study reports extensive work on
the viscoelastic nature of the OMBs that is crucial to explaining the behavior of OMBs in
the body cavities of blood vessels, depending on the route of administration.
The first objective of this research was to investigate the effect of DSPC, DBPC,
and DPPC lipid OMBs on improving the survival of rats with LPS-induced ARDS. The
ARDS rat model was replicated using a 24 mg/kg dose of LPS. The LPS was
intratracheally aerosolized, and the rats were monitored for signs of ARDS. The study
was performed in three phases with 10 rats (equal males and females) for each OMB
type. The OMBs were administered every 12 h via the IP catheter using 100 mL/kg. The
final OMB bolus was administered at 36 h. The rats displayed visible signs of ARDS and
had mild-to-moderate hypoxia. In certain cases, the rats showed severe hypoxia and died
prior to the 48 h study endpoint. Upon comparing the survival of rats in the three groups,
rats receiving DSPC OMBs had the highest survival rate of 77.2%, which was
significantly greater than 20% for DBPC and 10% for the DPPC groups. The SpO2 and
PaO2 continuously dropped for the DBPC and DPPC OMB groups across the different
study time points. As a result, the SpO2 and PaO2 remained comparatively greater in the
DSPC OMB group and led to greater survival of rats. The edema score of lungs from the
DSPC OMB group was significantly lower than the other two groups. Also, the wet/dry
ratio was lower for the DSPC group, but this difference did not reach statistical
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significance. Overall, the DPSC OMBs led to a significantly greater survival rate than the
other OMBs.
The second objective of this research was to investigate and characterize the
rheological behavior of OMBs of different volume fractions using a rotating rheometer.
The rheometer was used with a cone geometry with a 1° angle. All the OMB types
showed a shear-thinning behavior at 0.3, 0.5, 0.7, and the undiluted volume fractions. The
shear-thinning behavior was volume fraction and temperature-dependent. With the
increase in OMB volume fraction, the concentration increased, and as a result, the
viscosity of the OMB was greater for a given shear rate. Moreover, the viscosity
decreased with the increase in temperature since it was higher at 23 ℃ than at 37 ℃. The
apparent viscosity of the OMBs at a given shear rate and temperature followed the trend:
DBPC > DSPC > DPPC. This trend is attributed to the number of carbons in the
respective lipids. The OMBs showed a viscoelastic behavior when a frequency sweep
was applied. At lower angular frequencies, the loss modulus was greater than the storage
modulus giving rise to a predominantly liquid behavior. However, the storage modulus
was consistently higher at greater frequencies, resulting in a predominantly elastic
behavior in that frequency range. Moreover, the moduli increased with an increased
angular frequency, and both were greater for greater volume fractions showing a
concentration dependence.
The third objective of this research was to model the viscous behavior of the
different OMBs by using the shear-thinning fluid models. For this purpose, the Casson
model, Herschell-Bulkley model, and Power-law model were used. The models were fit
to the shear stress versus shear rate data using non-linear regression and were compared
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using the Akaike information criterion to identify the best model. For all the volume
fractions, the Herschell-Bulkley and power-law models showed a similar R2 value that
was greater when compared to the Casson model. The model fit was, therefore, better
than the Casson model. Moroever, R2 values were greater at 23 ℃ showing a better fit.
The best-fit parameters from the Casson and Herschell-Bulkley models provided the
predicted yield stress values. However, the latter provided parameters with wide 95%
confidence intervals and were, therefore, less reliable. The yield stress values predicted
by the Casson model were greater for greater volume fractions and lower at 37 ℃ than at
23 ℃. The yield stress values followed the trend DBPC > DSPC > DPPC at lower
volume fractions. The power-law index predicted by the models was n < 1, pointing
towards the shear-thinning nature of the OMBs, confirming results from the viscosity
studies.
This work's overall objective was to compare the rheological behavior of OMBs
with different lipid shells as a function of VF, temperature, and frequency and to
investigate the effectiveness of OMBs in improving the survival of rats with ARDS. This
objective was accomplished by administering OMBs with three different shell types on
rats with ARDS and comparing the survival outcomes. The rheological behavior was
studied using a rotating rheometer with a cone geometry for different volume fractions of
OMBs at room and body temperatures. The results of this research merit further
exploration of OMB administration in a larger animal model and studies exploring the
rheology of other non-lipid OMBs that can be potentially used in PMO therapy in the
future.
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CHAPTER 17 THE FUTURE WORK
The current work showed that the DSPC lipid OMBs led to higher survival of rats
with ARDS. These results confirmed the results previously reported by Fiala et al.,
wherein the DSPC OMBs led to a survival rate of 80%. This comparative study explored
the survival outcomes using different lipid shells. The greater efficacy of DSPC OMBs
was reported in this study. These results merit further exploration of these OMBs in large
swine models before being tested in clinical trials.
Artificial oxygen carriers have attracted greater attention in the past few years,
especially since the onset of COVID-19. These carriers have several limitations in terms
of side effects like thromboembolism, toxicity, and diffusion limitations. The OMBs
consist of shell material that is typically found in the lungs. As a result, they are
biocompatible and are considered safe. Since the splanchnic circulation is limited, the
OMBs and other OMB administration routes can be explored in small and large animal
models. Recently, an increasing interest has been shown in the rectal administration of
OMBs due to the easy administration without invasive catheter implantation and the
availability of a large surface area for oxygen absorption.
The OMB administration can be extended to applications not involving ARDS,
such as organ preservation, cancer treatment, scaffolds for wound healing, and tissue
engineering. Local tissue hypoxia renders cancer cells less responsive to radiation in a
tumor or cancer. As a result, chemotherapy becomes less efficient. Using OMBs to
deliver oxygen locally can increase the oxygenation of tumor cells and increase their
sensitivity to chemotherapy. Transportation of organs for transplantation is critical to its
success. Care is taken to prevent any degradation of the organs by storing them in an
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oxygen environment. The OMBs can be used for the storage of organs for critical
surgeries. There are different proteins and surfactants found in the lungs. These materials
can be used to synthesize shells for OMBs to compare their effectiveness with the lipid
OMBs giving a wide range of options for OMB administration. Since at least one of the
OMB formulations showed promising results, further studies could be designed to
investigate the oxygenation improvement at different time points after administering the
OMBs.
The rheology results from this work can be used as a guide to design further
experiments to investigate the mechanical properties of OMBs and the time-dependent
viscous behavior of OMBs (thixotropy and rheopexy). Additionally, the normal stresses
during the shear flow can be calculated to fully understand the flow behavior of OMBs at
large strain rates. A study of normal stresses will also provide an understanding of the
microstructure of the OMBs. These studies can be conveniently performed using a
rotating rheometer. Further, the rheological results can be correlated to the in vivo
oxygenation studies to determine how the changing viscosity resulting from the
increasing rigidity of the OMB lipid shell affects the release of O2 from the OMB core.
These studies can be very helpful for the future of OMB administration as a potential
treatment option for situations of critical trauma.
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APPENDICES
APPENDIX A RATS WITH IP AND FEMORAL CATHETERS

Figure A.1 OMB administration via the IP catheter.
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APPENDIX B CHEST RADIOGRAPHS
B.1 DSPC OMBs- Males
0 hours

24 hours

48 hours

Figure B.1 Chest radiographs of male rats in the DSPC OMB group at different time points
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B.2 DSPC OMBs- Females
0 hours

24 hours

48 hours

Figure B.2 Chest radiographs of female rats in the DSPC OMB group at different
time points

190

B.3 DBPC OMBs- Males
0 hours

24 hours

48 hours

Figure B.3 Chest radiographs of male rats in the DBPC OMB group at different time points
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B.4 DBPC OMBs- Females
0 hours

24 hours

48 hours

Figure B.4 Chest radiographs of female rats in the DBPC OMB group at different
time points
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B.5 DPPC OMBs- Males
0 hours

24 hours

48 hours

Figure B.5 Chest radiographs of rats in the DPPC OMB group at different time points

193

B.6 DPPC OMBs- Females
0 hours

24 hours

Figure B.6 Chest radiographs of female rats in the
DPPC OMB group at different time points
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APPENDIX C PLOT FOR %SaO2

Figure C.1 Plot showing %SO2 before and after the administration of different OMBs, time points post-LPS
administration.
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APPENDIX D WEIGHTS OF RATS

Figure D.1 Plot showing weights of rats in different OMB groups.
The x-axis shows time points post-LPS administration.
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APPENDIX E COMPARISON OF VISCOSITIES OF LIPID OMBs
E.1 0.3 volume fraction

Figure E.1.1: Comparison of the viscosity of DSPC, DBPC, and DPPC OMBs at 0.3 VF at 23 ºC.

Figure E.1.2: Comparison of the viscosity of DSPC, DBPC, and DPPC OMBs at 0.3 VF at 37 ºC.
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E.2 0.5 volume fraction

Figure E.2.1: Comparison of the viscosity of DSPC, DBPC, and DPPC OMBs at 0.5 VF at 23 ºC.

Figure E.2.2: Comparison of the viscosity of DSPC, DBPC, and DPPC OMBs at 0.5 VF at 37 ºC.
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E.3 0.7 volume fraction

Figure E.3.1: Comparison of the viscosity of DSPC, DBPC, and DPPC OMBs at 0.7 VF at 23 ºC.

Figure E.3.2: Comparison of the viscosity of DSPC, DBPC, and DPPC OMBs at 0.7 VF at 37 ºC.
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APPENDIX F STORAGE AND LOSS MODULI WITH STANDARD
DEVIATIONS
F.1 DSPC OMBs

Figure F.1.1 Storage and loss modulus of DSPC OMBs at different VFs for 23 ºC.

Figure F.1.2 Storage and loss modulus of DSPC OMBs at different VFs for 37 ºC.
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F.2 DBPC OMBs

Figure F.2.1 Storage and loss modulus of DBPC OMBs at different VFs for 23 ºC.

Figure F.2.2 Storage and loss modulus of DBPC OMBs at different VFs for 37 ºC.
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F.3 DPPC OMBs

Figure F.3.1 Storage and loss modulus of DPPC OMBs at different VFs for 23 ºC..

Figure F.3.2 Storage and loss modulus of DBPC OMBs at different VFs for 37 ºC..
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APPENDIX G
The G’ and G” comparison for different OMB types at various VFs

Figure G.1 Comparison of G’ and G” for different OMB types at undiluted VF at 23 ºC.

Figure G.2 Comparison of G’ and G” for different OMB types at undiluted VF at 37 ºC.
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Figure G.3 Comparison of G’ and G” for different OMB types at 0.7 VF at 23 ºC

Figure G.4 Comparison of G’ and G” for different OMB types at 0.7 VF at 37 ºC
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Figure G.5 Comparison of G’ and G” for different OMB types at 0.5 VF at 23 ºC

Figure G.6 Comparison of G’ and G” for different OMB types at 0.5 VF at 37 ºC
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Figure G.7 Comparison of G’ and G” for different OMB types at 0.3 VF at 23 ºC

Figure G.8 Comparison of G’ and G” for different OMB types at 0.3 VF at 37 ºC
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APPENDIX H
OMB VISCOSITY AT 23 ºC AND 37 ºC
H.1 DSPC OMBs

Figure H.1 Comparison of the viscosity of DSPC OMBs with different VFs at 23 ºC and 37 ºC..

H.2 DBPC OMBs

Figure H.2 Comparison of the viscosity of DBPC OMBs with different VFs at 23 ºC and 37 ºC.
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H.3 DPPC OMBs

Figure H.3 Comparison of the viscosity of DPPC OMBs with different VFs at 23 ºC and 37 ºC.
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APPENDIX I BEST FIT PARAMETERS FOR DSPC OMBs
** The 95% confidence interval is very wide.
Table I DSPC OMB
VF-temperature

0.3-23

0.5-23

0.7-23

U-23

0.3-37

0.5-37

0.7-37

U-37

Consistency
index

Yield stress

(mPa.s)

(Pa)

C

0.02

0.93

**

H

0.05

0.08

0.56

P

0.08

C

0.02

1.7

**

H

0.17

4.9*10^-32

0.45

P

0.17

**

0.45

C

0.03

2.65

**

H

0.14

1.2*10^-7

0.63

P

0.14

**

0.63

C

0.04

3.33

**

H

0.13

4.93*10^-32

0.7

P

0.13

**

0.7

C

0.01

0.36

H

0.04

3.58*10^-6

P

0.04

C

0.02

1.1

**

H

0.15

4.9*10^-32

0.37

P

0.15

**

0.37

C

0.03

2.21

**

H

0.21

2.89*10^-8

0.52

P

0.13

**

0.59

C

0.03

2.34

**

H

0.11

1.26*10^-3

0.67

P

0.09

**

0.69

Model

Power law index

0.49

0.41
0.42
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APPENDIX J BEST FIT PARAMETERS FOR DBPC OMB
Table J DBPC OMB
VF-temperature Model Consistency index Yield stress

0.3-23

0.5-23

0.7-23

U-23

0.3-37

0.5-37

0.7-37

U-37

Power law index

(mPa.s)

(Pa)

C

0.004

1.1

**

H

0.17

4.89*10-8

0.23

P

0.17

**

0.22

C

0.01

1.54

**

H

0.15

0.13

0.40

P

0.22

**

0.34

C

0.02

1.99

**

H

0.14

7.69*10-9

0.67

P

0.12

**

0.69

C

0.02

1.99

**

H

0.14

7.69*10-9

0.67

P

0.12

**

0.69

C

0.004

1.12

**

H

0.17

4.98*10-8

0.23

P

0.17

**

0.22

C

0.004

1.51

**

H

0.35

4.9*10-32

0.18

P

0.35

**

0.18

C

0.01

1.67

**

H

0.14

0.13

0.48

P

0.20

**

0.43

C

0.02

1.91

**

H

0.09

0.15

0.69

P

0.13

**

0.63
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APPENDIX K BEST FIT PARAMETERS FOR DPPC OMB
Table K DPPC
OMB
VF-temperature Model Consistency index Yield stress

0.3-23

0.5-23

0.7-23

U-23

0.3-37

0.5-37

0.7-37

U-37

Power law index

(mPa.s)

(Pa)

C

0.02

0.65

**

H

0.06

2.68*10-9

0.50

P

0.04

**

0.57

C

0.02

1

**

H

0.08

4.9*10-32

0.51

P

0.08

**

0.51

C

0.03

2.03

**

H

0.10

5.64*10-8

0.66

P

0.08

**

0.71

C

0.03

1.74

**

H

0.09

0.05

0.62

P

0.10

**

0.59

C

0.01

0.36

**

H

0.03

4.9*10-32

0.50

P

0.03

**

0.50

C

0.01

0.5

**

H

0.04

5.9*10-9

0.51

P

0.04

1.59

0.54

C

0.03

1.59

**

H

0.07

4.93*10-32

0.67

P

0.07

**

0.67

C

0.02

0.89

**

H

0.08

4.0*10-9

0.52

P

0.06

**

0.57

